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Introduction
This issue of the MEDICAL COLLEGE OF VIRGINIA QUARTERLY is an edited form of the
proceedings of the Cardiac Pacing symposium held in
Williamsburg, Virginia on April 16 and 17, 1971 The
meeting was co-sponsored by the American College of
Cardiology and the Department of Continuing Education, Medical College of Virginia, Health Sciences
Division, Virginia Commonwealth University The
program emphasized the clinical aspects of cardiac
pacing, and the format was structured with formal
presentations followed by panel discussions. Manuscripts were not requested from the speakers, and with
the exception of Dr Philip Samet who prefers that the
reader review the publications listed on p. 173 rather
than rely on the transcriptions of his talks, "Hemodynamics and Electrical Studies in Pacing" and "Indications for Temporary Pacing," bibliographic references
are not included. The success of this meeting which
approximately three hundred attended must be attributed to the outstanding guest faculty whose contributions in the past are largely responsible for the
presently employed techniques. Dr Onkar Narula
was an unscheduled speaker who kindly consented
to present his experience with His bundle recordings
during the session on temporary pacing. The interest
aroused by the program reflects the realization by
physicians of the growing impact of engineering in
clinical medicine.
I would like to express my appreciation to Mr William Nelligan and Miss Mary Anne Mcinerny and
other members of the staff of the American College of
Cardiology who assisted in the organization of this
meeting. I am grateful for the support provided by
Dr M. Pinson Neal, Jr and Miss Erma Blanchard of
the Department of Continuing Education as well as
Mr Melvin Shaffer and his staff of the Audio-Visual
Department. I would like to acknowledge the work required in the preparation of this manuscript by my
secretary, Mrs. Barbara Hendrick, and by the editorial
staff of the MEDICAL COLLEGE OF VIRGINIA
QUARTERLY, particularly Mrs. Ronnie Madoff and
Miss Mary Parke Johnson.
CHARLES L. BAIRD, JR., M.D.
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Historical Development of Cardiac Pacing*
PAUL M. ZOLL, M.D.

Clinical Professor of Medicine, Harvard Medical School and Associate
in Medical Research, Beth Israel Hospital, Boston, Massachusetts

I would like to discuss the development and historical aspects of cardiac pacemaking from a personal
point of view, presented as it appeared to me over the
years. This approach is biased, selective, and incomplete, but I think as informative as I can make it.
It has long been known, indeed from the early days
of Galvani, that electrical currents have effects on the
heart. The knowledge that a cardiac contraction may
result from an electrical stimulus led to no clinically
useful result until relatively recently Other instances
are common perhaps even at the present time in
medicine in which basic information is available for
advances in therapy but is not being used.
There was not much change in this field until about
1900, when a great deal of research was conducted on
the effects of electrical currents on the heart. It was
demonstrated in physiological and pharmacological
laboratories then that electrical stimuli produced action
currents that were conducted along nerve or muscle
cells, and produced contractions in skeletal, smooth,
and cardiac muscle. Among the important contributors
were Adrian, Evans, and John Erlanger In 1900,
Prevost and Batelli demonstrated that electrical currents, both direct-current and alternating-current discharges, would terminate ventricular fibrillation. The
shocks were applied directly to the heart, but it took
a very long time again before this information was
used effectively In 1933, Hooker, Kouwenhoven, and
Langworthy made extensive and valuable laboratory
studies on the effects of alternating current in terminating ventricular fibrillation, again the current was
applied directly to the exposed heart. This work was
extended in 1936 by Ferris, King, Spence, and Williams, who demonstrated that capacitor discharges
also terminated ventricular fibrillation. They used
sheep, relatively large animals, with hearts similar to
man's in size, but again information lay dormant
without human, clinical application. In 1946, some
Russian workers, Gurvich and Yuniev, recorded very
briefly in the English literature that capacitor discharges would terminate ventricular fibrillation . About

* Presented at the American College of Cardiology and
the Medical College of Virginia Cardiac Pacing Symposium, April 16 and 17, 1971, Williamsburg, Virginia.
MCV QUARTERLY 7(4): 127·130, 1971

1940, Wiggers and Wegria conducted extensive experimental studies outlining the various features of
electric shock that were useful in terminating ventricular fibrillation. Wiggers demonstrated that an
initial alternating-current shock might produce ventricular fibrillation in a normally beating heart and a
second shock of the same nature but perhaps a little
stronger might terminate the fibrillation. Wiggers applied the term "countershock" to this procedure,
which I like to use and keep alive despite current usage
of other terms because of its historical significance.
I think we should give him credit for providing us
with the sound experimental basis for the technique
of defibrillation which has saved so many lives. The
first clinically successful termination of ventricular
fibrillation in man was done in 1947 by Beck, Pritchard, and Feil, who resuscitated a patient from ventricular fibrillation by performing emergency thoracotomy, direct cardiac "massage," and application of
alternating current to the exposed heart. In this very
brief review of direct ventricular defibrillation, I have
passed over some instances in 1902 and 1910 of
defibrillation that were unsuccessful. In 1947, Claude
Beck and his group in Cleveland had established that
opening the chest and applying a-c countershock would
terminate ventricular fibrillation, this procedure formed
the basis for the treatment of cardiac arrest that was
widely taught and vigorously practiced in those days.
In the presence of cardiac arrest, under any circumstances one was supposed to cut the chest open,
"massage," i.e. squeeze the heart rhythmically to
provide an effective output, and if necessary to defibrillate the heart by direct application of alternatingcurrent countershocks.
In 1932, Dr Albert S. Hyman in New York City
addressed himself to the parallel problem of ventricular standstill. He attempted to develop an effective
means of stimulating the heart in ventricular standstill
so as to terminate cardiac arrest. He applied a stimulus
from an electric pacemaker to the atrium by passing
a long needle or electrode through the chest wall into
the atrial musculature. He demonstrated effective
atrial stimulation in the rabbit by this technique, but
it was never applied successfully in man as far as I
know A major difficulty lay in the maintenance of
good contact of the needle electrode in the cardiac
127
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muscle without displacement or injury Another problem was in the application of the stimulus to the
atrium, in clinical cardiac arrest atrioventricular block
is often present so that atrial beats are not conducted
and do not arouse ventricular contractions.
In their extensive studies in 1940, Wiggers and
Wegria examined the effects of electric stimuli of
varying intensity and duration at varying intervals after
a preceding beat, and clearly delineated the various
phases of cardiac excitability They demonstrated and
applied the term "vulnerable phase" to the interval
in the relative refractory period when a strong (well
above threshold for a single response) or long stimulus
produces multiple or repetitive beats and even fibrillation. The stimuli used in these studies were 10 milliseconds long, whereas present-day pacemakers provide
stimuli usually less than 2 milliseconds long. This explains why they were able to demonstrate repetitive
responses and the vulnerable period so readily
I became interested in electric stimulation of the
heart shortly after World War II, after I had observed
much of the pioneering cardiac surgery done by Dr
Dwight Harken for the removal of foreign bodies
in and about the heart. The heart appeared, indeed,
to be a very sensitive organ that responded readily
with ventricular contractions to stimuli, arousal from
ventricular standstill by appropriate stimulation should,
therefore, not be difficult. The other point with which
I was impressed I should have learned in first-year
anatomy-the esophagus lies behind the heart in very
close contact with it. Thoracotomy and direct electrical
stimulation of the heart seemed to be an inappropriate and excessively traumatic approach to the problem of effective cardiac stimulation that was not much
better than the universally accepted program of thoracotomy, cardiac massage, and direct countershock
defibrillation. It seemed to me that a stimulus might
arouse a ventricular contraction in a patient with
cardiac arrest if it were applied in the esophagus close
to the heart by way of a long wire electrode passed
down the mouth.
I thought about this matter for some time but did
not do much about it, I am afraid, for a long while.
My background in electricity was inadequate, so I
did not know how to build a pacemaker that would
provide an appropriate stimulus. In 1950, William C.
Callaghan, a Canadian cardiac surgeon, spoke at a
Boston Surgical Society meeting and described an approach of passing a wire electrode "catheter" down
the jugular vein in a dog, and stimulating the area
of the sino-atrial node to provide an effective rhythm
controlled by an external pacemaker This method
has not been used clinically but it is very interesting
and it contains elements of many of our present-day
techniques, especially the idea of applying an electric
stimulus by way of a pervenous endocardial "catheter"
wire electrode. He made a great effort to apply it to the
128

sino-atrial node, not an appropriate site for ordinary
clinical purposes in patients with A-V block, but one
that is being reconsidered for special purposes now
I found that he used a standard physiologic pacemaker
made by the Grass Instrument Company in Quincy,
Mass., and within the next year I managed to borrow
one from Dr Otto Krayer, head of the Pharmacology
department of the Harvard Medical School. With a
long wire electrode in the esophagus and a second
electrode over the precordium in a dog, I was quickly
able to demonstrate that electrical stimuli would indeed
arouse atrial or ventricular electrical responses and
effective muscular contractions with which cardiac
arrest could be terminated and the circulation maintained. An extensive laboratory study was undertaken
to develop the details of this new technique of external
electric stimulation of the heart, to improve and
simplify the procedure and the apparatus, to define its
clinical applicability and limitations, and to expose
any associated hazards. It was soon found that rather
large currents were necessary for effective stimulation
(30 to 150 volts or 50 to 200 milliamperes) unless the
negative electrode actually touched the heart, and that
two surface electrodes on each side of the precordium
were as effective as an esophageal-precordial pair
Short stimuli, 2-3 milliseconds in duration, were
selected when they were found to be almost as effective as longer ones in stimulating single responses
and never produced repetitive responses, tachycardia,
or fibrillation except in hearts seriously damaged by
ischemia, anoxia, or overdoses of digitalis or quinidine.
In 1952, we applied the method of external electric
stimulation for the first time in man, and it quickly
became established as an effective emergency means
of arousing the heart from ventricular standstill. Although most frequently used in patients with StokesAdams disease, it was also effective in standstill of
any origin, even in the absence of A-V block, so long
as cardiac contractility was not overly depressed by
prolonged anoxia or drugs. Although external stimulation was occasionally used in desperate circumstances for hours or days to maintain an artificial
rhythm, it proved too painful for ordinary long-term
use. For the purposes of arousing, accelerating, and
maintaining intrinsic ventricular rhythms in patients
with high-degree A-V block, Dr Arthur J Linenthal
and I developed the method of intravenous administration of dilute solutions of sympathomimetic amines,
particularly epinephrine and isoproterenol. Combined
use of the two methods often enabled us to keep patients alive through intervals of severely unstable
rhythm and frequent Stokes-Adams attacks.
We also found at that time that provision of a rapid
regular rhythm by external electric stimulation or by
acceleration of an intrinsic pacemaker pharmacologically would often stop recurrent ventricular tachycardia and fibrillation. This demonstration lies behind

PAUL M. ZOLL
the concept of overdriving the heart to suppress multiple competing rhythmic foci, which is an important
aspect of present-day control of cardiac rhythm with
electric pacemakers.
The method of external electric cardiac stimulation
is based on the idea of applying a large electric current to the surface of the chest so that a small portion
of it may reach the heart and stimulate a response,
just as a small electric stimulus applied directly to the
exposed heart was known to do. The success of this
technique suggested modification of the usual countershock defibrillation after thoracotomy by application of
a large countershock externally across the surface of
the chest. In 1954, contemporaneously with William
Kouwenhoven at Johns Hopkins and Arthur C. Guyton at the University of Mississippi, we developed a
technique for external electric countershock defibrillation with large 60-cycle alternating-current shocks
in dogs and domestic pigs. The next year we applied
it successfully for the first time to resuscitate a patient
from ventricular fibrillation. We also demonstrated in
the laboratory that external a-c countershock would
terminate every type of rapid arrhythmia. atrial tachycardia, atrial fibrillation, ventricular tachycardia, and
ventricular fibrillation. In 1955, we terminated several
desperate attacks of ventricular tachycardia and in
1957 one of atrial tachycardia in man with external
a-c countershock. In 1961, Bernard Lown at the Peter
Bent Brigham Hospital greatly modified this approach
by applying external direct-current shocks (obtained
by capacitor discharge through an inductance) that
were synchronized to fall immediately after the R
wave so as to avoid the vulnerable phase of the cardiac
cycle. He used this method, which he termed "cardioversion," for the elective termination of lesser arrhythmias with the thought that synchronization would
prevent the production of ventricular fibrillation. Although some disagreement with this view persists
(from myself and other workers as well), the technique of synchronized d-c shock is most generally
used today The initial enthusiasm for cardioversion
of minor arrhythmias has subsided considerably because of the frequent early recurrence of the arrhythmia with little clinical benefit.
The development of these two methods of external
electric stimulation and of external electric countershock led to great changes in the management of
cardiac arrest. With effective emergency means of
arousal of the heart from standstill and of defibrillation without the need for thoracotomy, programs of
action became simpler, less traumatic, and more
successful. The unpredictability of attacks and the
limited time available for resuscitation pointed to the
need for prompt recognition of the onset of arrest and
identification of the arrhythmia. From our early experiences with patients with Stokes-Adams disease
came the development of cardiac monitors in 1954

that provide an audible signal of each beat, continuous
visual display of the electrocardiogram, an alarm signal
of appropriate changes in rate, and prompt, even
automatic availability of an external electric pacemaker In 1960, William Kouwenhoven developed the
technique of "external cardiac massage," or external
cardiac compression, by which circulation of blood
may be restored immediately in the emergency of
cardiac arrest and, if necessary, the time interval for
more definitive management of arrhythmia may be
extended.
In 1963, Hughes Day combined all these techniques
and applied them to patients with acute myocardial
infarction, the largest group with serious arrhythmias.
He placed patients with this condition under continuous monitoring in a coronary care unit where
monitors, pacemakers, and defibrillators were concentrated together with personnel expert in their use and
trained in a program for management of cardiac arrest.
His demonstration in the pioneer unit at Bethany,
Kansas, of a major reduction in mortality from acute
myocardial infarction led to the widespread acceptance
of the concept of the coronary care unit.
It seems unfortunate to me, however, that the idea
of continuous cardiac monitoring has not been applied
widely to surgical operating rooms where unexpected
cardiac arrest still occurs with significant frequency
and mortality In 1963, Drs. Morris Nicholson and
Joseph Crehan, anesthesiologists at the New England
Deaconness Hospital in Boston, monitored a number
of very sick patients throughout anesthesia. In this
group they demonstrated a · striking improvement in
successful resuscitation from cardiac arrest. Despite
this convincing experience, continuous cardiac monitoring with automatic alarm has not become a
standard part of the management of all patients undergoing anesthesia, as I believe it should.
The final subject of discussion is the development
of internal cardiac pacemakers for the long-term provision of a reliable rhythm at any rate desired. The
need for a method of prolonged cardiac stimulation
was obvious early in our experience with patients
with Stokes-Adams disease, when we were able to
resuscitate patients from attacks of standstill or fibrillation but were unable to prevent recurrent episodes.
Direct cardiac pacing with small, imperceptible electric stimuli by means of electrodes implanted in the
myocardium had long been known and used experimentally, but for years long-term pacing in this way
was frustrated by a progressive rise in threshold for
stimulation. In 1958, Thevenet, Hodges, and Lillehei
in Minneapolis attempted to stimulate the heart
directly in patients with Stokes-Adams disease with
a stainless-steel electrode placed in the myocardium
at thoracotomy that was connected to an externally
carried pulse generator Stimulation failed uniformly
within 7 weeks, however, because of increasing thres129
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hold for cardiac response. We finally recognized the
problem as a foreign-body tissue reaction to minute,
sterile contaminants on the electrode surface and
solved it by using inert metals for the active electrode
(platinum, gold, or stainless steel) and by boiling it
in Ivory soap flakes. Dr Samuel A. Hunter in St.
Paul developed the Hunter-Roth electrode and with
it was the first in 1959 to achieve long-term pacing
in a patient with Stokes-Adams disease. In 1960,
Ors. William Chardack, Adrian Kantrowitz, and
Howard Frank and I began series of implantations of
pacemaker-electrode systems by way of thoracotomy,
and adequate long-term management of A-V block
and Stokes-Adams disease was finally accomplished.
Many problems arose and many changes were made
in long-term cardiac pacing to meet them. Displacement of electrodes, wire breakage, and component
failure in the pulse generator have in large measure
been corrected, but early battery depletion remains
the major difficulty at present. An important modification, which has become widely accepted, has been in
the placement of a pervenous endocardial "catheter"
electrode under fluoroscopic control rather than by
thoracotomy This approach was first introduced by
Ors. Seymour Furman and John Schwede! at the
Montefiore Hospital in New York City with the electrode passed through an antecubital vein and connected to an externally carried pulse generator Subsequently, other veins were used and the entire
pacemaker system was placed subcutaneously Although the procedure is relatively minor, it is not
entirely satisfactory in that electrode placement is
sometimes very difficult and even unsuccessful, and
electrode displacement, myocardial perforation, high
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threshold for stimulation, and wire breakage occur
with small but significant frequency In this regard,
we have recently developed an "arrowhead" electrode
that may be inserted rather quickly and securely
through a small thoracotomy but under direct vision.
This technique is an attempt to gain the advantages
of both approaches-secure placement of the electrode
in the myocardium but with a relatively small, welltolerated procedure.
In recent years, many types of pacemakers have
been developed to avoid competition of an independent
fixed-rate pulse generator with intrinsic beats, which do
occur often from ectopic ventricular foci or from
return of A-V conduction. It appears that competition offers little risk clinically of repetitive response
and ventricular fibrillation, unless an electrode is
inserted in an area of acute myocardial ischemia or
infarction. Nevertheless, variable-rate ("synchronous,"
"demand," or "stand-by" ) pacemakers may at times
be advantageous in producing less palpitation and
better cardiac output. Atrial-triggered, ventriculartriggered and inhibited, and atrial-ventricular sequential pulse generators of many varieties have been developed, and some are now being widely used.
Presently, both temporary and long-term pacing
are also being applied with considerable enthusiasm
in a variety of clinical situations and to a wide variety
of difficult arrhythmias. Consequently, the area of
applicability of cardiac pacing is growing. Advances
in technology and engineering also promise major improvements in new generations of pacemakers so that
we can anticipate exciting developments in the whole
field of electrical control of cardiac rhythm.

Pacemaker Concepts and Terminology*
BAROUH V

BERKOVITS, E.E., Ing.

Associate in Surgery, Harvard Medical School, Boston, Mass., Associate in
Electrophysiology, Miami University, Miami, Fla., Senior Research Scientist,
Cedars-Sinai Medical Research Institute, Los Angeles, Calif., Consultant in
Surgery, Peter Bent Brigham Hospital, Boston, Mass., Cardiovascular Research
Manager, American Optical Corporation, Framingham, Mass.

Since the introduction of implantable cardiac pacing
systems there have been marked advances in concept
and design of the equipment available. Whereas intracardiac pacing is usually identified with A-V conduction disturbances, recently gained knowledge of
cardiac physiology has shown that electrical stimulation of the heart can be beneficial in the treatment
of many arrhythmias. It is important that the physician familiarize himself with the different modalities
of pacing. The terminology used to describe the
different concepts must be clear and precise so the
physician can select the proper pacemaker concept
for his patient without ambiguity
Pacemakers can be divided into two categories.
parasystolic and nonparasystolic. While parasystolicstimulation is independent of intrinsic activity; nonparasystolic-stimulation is controlled by the intrinsic
activity The nonparasystolic pacemakers can be either
inhibited, in which intrinsic signals suppress stimulation, or triggered, in which intrinsic signals induce
stimulation. According to the site of stimulation the
pacemakers can be atrial, ventricular, or A-V sequential. Pacemaker types in present use are
1 Parasystolic (Continuous)
a. Fixed or set rate atrial pacer
b. Fixed or set rate ventricular pacer
c. Fixed or set rate A-V sequential pacer
2. Triggered (Synchronous)
a. P-wave triggered ventricular pacer
b. QRS triggered ventricular pacer
3. Inhibited (Demand)
a. P-wave inhibited atrial pacer
b. QRS inhibited ventricular pacer
c. QRS inhibited A-V sequential (Bifocal)
The parasystolic pacemakers (continuous fixed rate)
may be used to stimulate the atria, ventricles, or
stimulate both the atria and ventricles with a preset
sequential delay In the presence of natural beats the
modality of stimulation is not affected and it competes
with the intrinsic activity The stimuli falling in the
absolute refractory period will induce no response,

* Presented at the American College of Cardiology and
the Medical College of Virginia Cardiac Pacing Symposium, April 16 and 17, 1971, Williamsburg, Virginia.
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but those falling in the vulnerable interval may induce
repetitive response or even fibrillation.
Figure 1 illustrates the differences between the
various modalities of nonparasystolic pacing.
Characteristics of P-wave triggered ventricular pacing are ( 1) The P waves trigger the pacemaker,
which in turn stimulates the ventricles synchronou~ly
after a preset delay of 120 milliseconds. (2) This
pacer usually has a refractory period of 500 milliseconds (measured from the beginning of the P wave)
which prevents the pacemaker from following atrial
tachycardia or fibrillation. ( 3) When natural P waves
do not appear for a preset interval ( 1.04 sec.) the
P-wave triggered pacemaker escapes. This escape
mechanism protects against asystole when there are
no P waves present. Thus, the pacemaker works either
in synchronous or escape modality
Characteristics of QRS triggered ventricular pacing
are · (1) The QRS complexes trigger the pacemaker,
which in turn stimulates the ventricles during its
absolute refractory period . In the latest models, this
synchronized stimulation is delivered immediately
after the detection of the ventricular endocardiac
signal. (2) The pacemaker has a refractory period
of 400 to 500 milliseconds. This built-in refractory
period is designed to protect the unit from running at
fast rates. A long refractory time may prevent the
recognition of premature beats and thus causes escape
stimulation competing with these premature beats.
Competition with premature beats is even more
hazardous than with the normal beats. (3) When
natural QRS complexes do not appear for a preset
interval ( 840 milliseconds), pacemaker escapes occur
to protect against asystole.
Contrary to the triggered pacemakers, the demand
pacemakers work only in escape mode. (1) In the
presence of a faster natural rhythm, the demand
pacemaker is dormant and no stimuli are delivered
to the heart. (2) Stimuli are delivered only if the
natural beat fails to occur for a preselected escape
interval. Consequently, the heart is stimulated only
when needed (on demand), and competitive rhythms
or stimulation during the vulnerable phase are thus
avoided.
Figure 2 shows how the ventricular demand or
131
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Fig 6------Bifocal pacemaker placed in a patient with sinus
bradycardia and premature ventricular contraction.

B FOCAL DEMAND PACEMAKER

Fig 7-Bifocal pacemaker placed in a patient with first
degree A-V block,

B FOCAL DEMAND PACEMAKER

O N-M AG NET- O FF
TES TIN G RESPO N SE O F VENTRI CULAR STIMULAT IO N

Fig 8-Testing of a pacemaker with a magnet; unit is converted to a fixed-rate mode.
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inhibited pacemaker actually works, imitating the
natural escape rhythm of an automatic fiber The
upper part of the tracing demonstrates how the automatic fiber works and how the threshold potential
is reached during phase four depolarization so that
these fibers can fire by themselves and produce
escape beats. The bottom portion of the figure demonstrates how the pacemaker is controlled by a capacitor that restores its charge with each detected beat.
In short, each time a depolarization signal is detected the pacemaker is reset and the timing cycle
is started again, When the capacitor's charge reaches
the critical level because of the prolonged interval ,
it permits escape and a stimulus is delivered to the
ventricle. The pacemaker actually delivers its stimulation in the same fashion as an automatic fiber
Figure 3 demonstrates schematically the different
modalities of pacing, As shown, Bifocal pacing is
similar to A-V sequential pacing, except that it is on
demand and it is inhibited and reset by endocardial
ventricular depolarizations. The Bifocal demand pacemaker adapts its modality of stimulation to the patient's need. It combines the advantages of atrial, A-V
sequential, and demand stimulation. It may remain
dormant, it may stimulate only the atria, or it may
stimulate both the atria and the ventricles with a preset
sequential A-V interval. The Bifocal demand pacemaker does not compete with the spontaneous ventricular activity and it has no significant refractory
time.
Figure 4 illustrates the basic construction of the
Bifocal demand pacemaker and compares it to the
conventional demand unit. In conventional demand
pacing the ventricular signal detected by a QRS detector will control the timing circuit of the ventricular
demand stimulator A magnetic switch is incorporated in these pacers for evaluation of pacemaker
function by preventing inhibition and thus converting
the unit to a fixed-rate mode. When testing the pacemaker, the rate produced by the magnetic switch is
independent of the patient's physiological condition
and should be used to determine the condition of the
batteries. It is important that during each outpatient
visit the demand pacemaker be checked by applying
a magnet and this rate recorded for control. Conceptually, the Bifocal pacemaker is comparable to
the conventional demand pacemaker except that
atrial stimulation controlled by the same QRS detector has been added.
Two functions of the Bifocal pacemaker are demonstrated in Figs. 5, 6, and 7 Figure 6 shows a
Bifocal pacemaker in a patient with sinus bradycardia
and premature ventricular contractions. It can be
observed that the atrial pacemaker compensates for
the premature ventricular beats. Figure 7 shows a
Bifocal pacemaker in a patient with first-degree A-V
block. The sequential interval of the pacemaker was
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similar to the patient's own conducted A-V interval.
Therefore, the different degrees of fusion and changes
in morphology can be observed.
Figure 8 depicts the testing of a Bifocal pacemaker
with a magnet, similar to the ventricular demand
pacemaker. The measurement of the interval during
a magnet-induced fixed-rate mode should be recorded
in order to follow the pacemaker function and determine battery condition. A change greater than 10
percent indicates battery failure.
During the past 18 months we have implanted 60
Bifocal pacers with encouraging results. In the early
stages, the basic indication for implantation of Bifocal
pacers was to improve cardiac output. Recently, Bifocal pacemakers have also been used for patients
with sick sinus syndrome-atrial brady-tachyrhyth-

mias. In a number of patients, we have found that
2 to 3 months after implantation, drugs could be
progressively discontinued, and that the atrial stimulation not only protected against the bradycardia but
also suppressed the episodes of tachycardia.
Pacing therapy has undergone marked evolution
during its relatively brief existence. Further developments in concept, clinical applicability and technical
areas are forthcoming. The physician has the obligation to understand the various pacing modalities and
to select the most suitable concept of pacing for each
particular disorder (Table I)
Author's note. "BIFOCAL" is a trademark of the
American Optical Corporation for the QRS inhibited
A-V sequential pacemaker

TABLE I
THREE DIFFERENT MODALITIE S OF A-V PACING

P-wave Triggered

A- V Sequential
(continuous

Bifocal Demand

For Normal Atrial Activity
With A- V Block

For Atrial Bradycardia
With A-V Block

For Atrial Bradycardia
With or Without A-V Block

Monitors P- waves

No monitoring

Monitors QRS Complexes

P-waves Contro l v entr icu l ar
Stimulation No Atria l
Stimulation Available
Stimulation is Delivered to
the v entric l es Continuous l y

Continuous Atrial and
ventricu lar Stimu lati on

Stimulation is Delivered Both
t o the Atria and Ventricles
Continuously

QRS Comp lexes Control Both
Atrial and Ventricular
Stimulation
Stimulation May Be:
a Totally Absent
b Delivered only to the Atria
c Delivered both to the Atri'a
and Ventricles
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Electrocardiographic Recognition of the
Various Pacemaker Types and Dysfunction*
LEONARD S. DREIFUS, M.D.

Research Associate Professor of Physiology and Biophysics,
Hahnemann Medical College and Hospital, Philadelphia, Pennsylvania

This discussion deals with electrocardiographic interpretations of the various types of pacemakers as
well as with their dysfunction which may be due to
pulse generator failure, wire breakage, change in threshold, or polarization of the ventricle. Hemodynamic
problems may also arise concerning placement of the
pacemaker leads particularly in those patients who lack
atrial contribution.
Figure 1 demonstrates competition resulting from a
fixed-rate pacemaker. Here are four different types of
beats showing the various responses that may occur.
It is important to point out that if a T wave is not
observed after a pacemaker spike then there is no
propagation of the impulse through the ventricle. I
prefer not to use this type of pacing because of competition and the possibility of sudden death, but as
yet we do not have any cases that verify such a situation. Figure 2 demonstrates the most serious form of
competition in which stimulation of the T wave had
resulted in ventricular fibrillation. I have observed
a number of cases in which the spike did occur on
the T wave but repetitive rhythms such as ventricular
tachycardia did not occur. However, with those patients who die suddenly one can only surmise that Twave stimulation and ventricular fibrillation could have
been related. I have no proof, but I am worried about
this problem as is everyone else. I believe that the
sicker the heart the more vulnerable it is and the
greater the chance of these complications.
One of the major concerns I have with fixed-rate
pacing is the problem of premature ventricular beats
other than those associated with ventricular fibrillation .
Figure 3, strip b, shows the development of premature
ventricular contractions after each paced beat which
result in a form of ventricular tachycardia that is
hazardous.
Noncompetitive pacemakers such as the R-wave
ventricular-triggered pacemaker (Fig. 3, strip c) have
a built-in refractory period, but as will be seen in the

* Presented at the American College of Cardiology and
the Medical College of Virginia Cardiac Pacing Symposium, April 16 and 17, 1971 , Williamsburg, Virginia.
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last portion of the strip, they do not sense all beats.
Figure 3, strip a, is an example of coupled rhythm
with an R-wave triggered pacemaker that does not
produce the form of ventricular tachycardia associated
with the fixed-rate unit.
The atrial-triggered pacemakers have given us a
host of headaches. There are not many of these around
anymore, but when the bifocal type becomes more
widely utilized we may run into similar difficulties
again. This patient (Fig. 4) developed atrial flutter
with an atrial-triggered pacemaker. Digitalization will
not work under these circumstances, and there is not
much you can do except shock the patient (strip d) .
I attempted to use quinidine, but the rate went up
to 140.
Figure 5 shows a premature ventricular contraction
which occurred during use of an atrial-triggered pacemaker. There is no refractory period built into the
unit, therefore, the ectopic beat is not sensed. This
could create a dangerous situation, and at least the
bifocal pacemaker, as Mr. Berkovits pointed out, does
not have this problem. In addition to runaway pacemakers, atrial-triggered units include such pitfalls as
this instance of a patient in complete A-V block and
intermittent function (Fig. 6). Here the "demand,"
or escape feature of the pacemaker was working, but
the atrial threshold increased tremendously, and the
atrial electrode was not sensing except in the supernormal period. You can occasionally see atrial-triggered beats coming through and evidence of bigeminy
which subsequently developed for some reason. There
is nothing wrong with this pacemaker unit. It was just
that the atrial circuit was working only intermittently
because of build-up of the threshold at the atrial lead.
One of the problems with atrial epicardial leads is that
after a period of time they may cease to function, and
you are again faced with fixed-rate pacing in a patient
with high-degree A-V block.
Rate hysteresis is another concern in using demand
pacemakers. In order to permit spontaneous sinus
activity, the escape rate is set at a slower driving frequency of 60 beats per minute while the driving rate
is set at 70 beats per minute. This allows the heart
to be paced in the presence of asystole. Following a
MCV QUARTERLY (7 (4) : 136·139, 1971
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Fig 1-Competition resulting from a fixed-rate pacemaker.
A, B, C, and D represent four types of beats, showing the
various responses that may occur.

Fig 3-(Strip a) coupled rhythm with an R-wave triggered
pacemaker; (strip b) development of premature ventricular contractions after each paced beat with a fixed-rate
pacemaker; (strip c) an R-wave ventricular-triggered pacemaker that is not sensing all beats.

Ventricular Fibrillation wi1h Implanted Cardiac Pacemakers

Robinson, D.S., el al.

Am

J. Cardiol. 15:397, 1965 •.

Fig 2-The most serious form of competition resulting
from a fixed-rate pacemaker. Strip 7 shows stimulation of
the Twave which results in ventricular fibrillation (strip 8).

Fig 4-Development of atrial flutter with an atrial-triggered pacemaker. Strips a and b represent an EKG recording of atrial flutter with an atrial-triggered pacemaker.
Strip c, documents the presence of flutter with a right atrial
electrogram. (Strip d) EKG recording after applied shock.
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period of sinus rhythm the pacemaker will not return
its pacing cycle for at least one second in order to permit slower sinus rates to emerge and maintain optimum
cardiac output.
Other problems with demand pacemakers are sometimes encountered. If the tip of the electrode catheter
is too close to the atria or the electrodes of the epicardial leads are too close to atrial tissue, P-wave
sensing may occur and cause a double reset of the
pacemaker. Also, large T waves occasionally can be
confused with QRS complexes, and these too can
reset pacemakers and produce long diastolic intervals.
Sometimes the electrogram does not quite reach two
millivolts, and incomplete sensing may occur. If the
pacing capacitors are not fully discharged they may
recycle at an earlier time and thus, the pacing cycle
is shorter than the expected ordinary driving cycle.
But in most instances the pacemaker corporations
have attempted to correct these problems.
In coronary sinus pacing, the pacemaker may be
located above or below the A-V junction. As Dr.
Samet pointed out, you have varying delays of propagation to the ventricle from His bundle recordings .
However, the coronary sinus is an unreliable place
from which to pace. I recently lost a patient completely dependent upon coronary sinus pacing when
the catheter flipped out.
The runaway pacemaker (Fig. 7) demonstrates a
situation which should no longer occur. For early
detection of this problem so that pulse generators
can be replaced, it is entirely possible that ten-hour
electrocardiographic taping may be of value.
I would now like to deal with some of the interesting aspects of cardiac pacemaking that relate to electrophysiology. In the past we did not know what the
supernormal period of the human heart was. We
discovered it in the laboratory when we stimulated
the heart at half threshold. The subsequent development of pulse generator failure shown in Fig. 8 reveals pacemaker spikes not followed by QRS complexes. However, the supernormal phase is identified
at the end of the T wave because of the propagated
response. Thus, a defunct pacemaker with less than
threshold stimulus remaining is able to propagate an
impulse during the supernormal period.
Another example of the supernormal period during
pacemaker failure is incomplete A-V dissociation in
the presence of 2-1 conduction block (Fig. 9). Why
do we get sudden conduction? And sudden conduction
occurring only after a paced spike? This is one of the
varieties of the so-called supernormal period of conduction. In some way this pacemaker spike is influencing subsequent transmission of facilitation of the next
P wave, and this offers an interesting insight into electrocardiographic analysis. The major problem in this
situation is to determine whether the failure is due to
a defunct battery, broken wire, threshold increase, or
138

Fig 5-A premature ventricular contraction which occurred during use of an atrial-triggered pacemaker.

Fig 6-An EKG recording of a patient in complete A-V
block and intermittent function using an atrial-triggered
pacemaker. The strips show that the atrial electrode is not
sensing except in the supernormal period. There is also
evidence of bigeminy.

Fig 7-Electrocardiographic recordings of a runaway pacemaker.
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Fig 8-Development of pulse generator failure. Pacemaker
spikes are not followed by QRS complexes, but the supernormal phase is identified at the end of the T wave because of the propagated response.

to actual myocardial contractions.
However, to avoid pacemaker failure, we now rely
on an early detection approach of rate counting and
recording the arterial pulse. Pulse information can
be recorded transtelephonically. Thus, if wire breakage
should occur you would see spike, pulse, spike, pulse,
spike and no pulse. This means that there was no
contraction of the ventricle and no peripheral pulse.
The rate is recorded by an interval counter, and if
there is a change of 15-20 milliseconds in an R-R
interval of 830 milliseconds, you can detect it and
recommend a pulse generator change. It is interesting
to note that 12 percent of our pacemakers are failing
before the indicated battery life span of 18 months.
This is a very serious problem, and it is our hope
that with the present technique of interval counting
we will be able to extend the life of the pulse generator
to 23 months.

PANEL DISCUSSION

Fig 9-Electrocardiographic recording of the supernormal
period during pacemaker failure in an instance of incomplete A-V dissociation in the presence of 2-1 conduction
block.

Dr. Richardson: Regarding the use of pacing to prevent ventricular tachycardia. Does this work by eliminating the VPC's which precipitate ventricular tachycardia or is there another mechanism?
Dr. Dreifus: When you have VPC's falling on the T
wave this can set up repetitive phenomena, and it
takes only one beat falling at the apex of T wave to
produce ventricular fibrillation. Now VPC's may be
due to reentry or to increased automaticity. By speeding up the ventricular rate you prevent asynchronous
diastolic depolarization and conduction abnormality.
When pacing assumes control of the heart it depresses
other pacemakers. Therefore, depression of the ectopic
pacemaker by the electric one will usually prevent
rhythm of development from occurring so that diastolic depolarization does not have a chance to take hold.
So there are two basic principles when you use overdrive: you cut down the tendency for inhomogeneous
depolarization and reentry, and at the same time you
keep the pacemaker depressed.
Questioner: Are you implying parasystolic focus is
also depolarized, practically speaking?
Dr. Dreifus: Parasystole implies that already there is
undirectional block. The undirectional block is built
into the pacemaker. It is true that you may not be
able to depolarize the parasystolic pacemaker, but then
the chances of its emerging to the rest of the heart
may then be inhibited. The most perfect example of
parasystole is the electrical parasystole. Obviously it
can't get into a fixed-rate pacemaker and so it is going
to emerge anyhow, and that is a problem. Fortunately,
most ventricular trachycardias with acute .infarction
are not parasystolic.
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Indications for Cardiac Pacing*
PAUL M. ZOLL, M. D.

Clinical Professor of Medicine, Harvard Medical School and Associate
in Medical Research, Beth Israel Hospital, Boston, Massachusetts

The indications for implantation of a long-term
cardiac pacemaker consist of two major categoriesthe prevention of Stokes-Adams attacks and an inadequate cardiac output caused by a slow ventricular
rate.
Stokes-Adams attacks are defined as episodes of
cerebral ischemia due to cardiac arrest in patients
who have atrioventricular block of any degree, not
only during the episode of arrest but at least intermittently at other times as well. One Stokes-Adams
episode presents an unquestionable, urgent indication
for pacemaker implantation. Questions may arise, however, about the extension of this indication to patients
who have high-degree A-V block but have not had
an attack. After all, Stokes-Adams attacks are notoriously unpredictable in frequency, severity, and
mechanism, and the first attack may be a fatal one.
When Stokes-Adams attacks may be considered to
have a significant probability, the risk of an initial
attack should perhaps be obviated by the implantation
of a cardiac pacemaker. A decision of this nature is
a matter of legitimate discussion at the present time.
The risks, disadvantages, and complications of the
procedure must be balanced against the risk of a
Stokes-Adams seizure. Many patients with high-degree
A-V block never have a Stokes-Adams seizure. Furthermore, in the presence of transient or reversible factors
(such as temporary anoxia, cardiac depressing drugs,
anesthetic agents, and acute rheumatic fever or diphtheria) even a documented seizure may not be a
sufficient indication for a pacemaker.
The indication may also be considered in patients
with multifascicular block, i.e. intermittent bilateral
bundle branch block, right bundle branch block plus
left anterior hemiblock. These patients may go on to
develop complete block and then perhaps suffer StokesAdams attacks. The likelihood of this development is
not entirely clear, however. Although many patients
with high-degree A-V block and Stokes-Adams attacks
are known to have had multifascicular block earlier,
it is not known how many of all the patients with
multifascicular block go through this sequence.

* Presented at the American College of Cardiology and
the Medical College of Virginia Cardiac Pacing Symposium, April 16 and 17, 1971, Williamsburg, Virginia.
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The indication for temporary pacemaker application to prevent Stokes-Adams attacks is even more
difficult to assess than for long-term use. It has been
proposed in patients with acute myocardial infarction
when first-degree A-V block or bundle branch block
appears, and even in uncomplicated inferior wall
myocardial infarction. Early enthusiasm for pacemaker
application in acute myocardial infarction has subsided considerably with the demonstration that this
procedure does not improve mortality statistics. The
placement of a catheter electrode often constitutes a
considerable, undesirable stress for the seriously ill
patient with acute myocardial infarction. Furthermore,
presence of the electrode in the chamber may provoke
dangerous ectopic ventricular activity. Finally, electric
stimulation of an ischemic area is especially hazardous
since the threshold for repetitive response and ventricular fibrillation is much lower in such an area than
in normal myocardium.
At times there may be great difficulty in making a
diagnosis of A-V block and even of cardiac syncope in
patients with intermittent seizures. A-V block may be
incomplete and intermittent, so as to escape detection.
Seizures that were thought to be neurological were
suffered two or three times a week for 35 years by one
patient in our series. His electrocardiograms repeatedly
showed normal sinus rhythm with normal intraventricular conduction. Finally, a tracing was obtained
from a cardiac monitor equipped with a "memory
loop" of recording tape and alarm system that showed
transient A-V block and ventricular standstill. His
disease was at last cured by the appropriate therapy
of implantation of a long-term cardiac pacemaker. His
electrocardiograms now almost always show competition of his normally conducted intrinsic ventricular
beats with the electrically stimulated beats of his fixedrate pacemaker, a phenomenon that produces no untoward clinical symptoms. Rarely, A-V block is present and only the pacemaker rhythm is seen.
A final extension of this primary indication for pacemaker application is concerned with the management
of cardiac arrhythmias in the absence of A-V blockso that the diagnosis of Stokes-Adams disease is technically improper. The provision of a reliable electrically
paced rhythm of appropriate rate will prevent syncopal
episodes due to depression of rhythmicity at any site
MCV QUARTERLY 7(4): 140-141, 1971

INDICATIONS FOR CARDIAC PACING
regardless of whether A-V block is involved. Furthermore, many tachycardias and even fibrillation may be
suppressed by overdriving with electric pacemakers
at a sufficiently rapid rate.
The second major indication for pacemaker implantation is an inadequate cardiac output due to a
slow ventricular rate. The slow rate may result from
a slow sinus rhythm with normal A-V conduction
or from varying degrees of A-V block. The inadequate cardiac output may be manifested by congestive
heart failure, by diminished tolerance for exercise and
consequent limitation of activity, by the presence of
angina pectoris, and by reduced renal and cerebral
function, i.e. azotemia and confusion or coma. The

reduction in renal and cerebral function may at times
be insidious and occult, and become apparent only in
retrospect after correction by a normal pacemaker
rate. In some patients with slow ventricular rates,
therefore, a temporary pacemaker at a fast rate should
be applied on a trial basis for several days to uncover
possible manifestations of inadequate cardiac output.
If no significant effect of a slow rate is found , it may
be a reasonable clinical judgment not to implant a
cardiac pacemaker, but to tolerate a harmless bradycardia. The only regular consequence of a slow ventricular rate is the appearance within a few months of
left ventricular hypertrophy.
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Techniques and Modes of Insertion
of Permanent Pacemakers*
LEWI S H. BOS HER, JR., M. D.

Associate Professor of Surgery, The Medical College of Virginia,
Richmond, Virginia

In this report, I intend to mention most of the methods of implantation of permanent pacemakers while
indicating those methods which are currently favored.
The special advantages of epicardial implantation of
pacemaking electrodes are the accuracy and reliability
of this technique, and the insignificant subsequent rise
in pacemaking threshold. However, the indications for
epicardial stimulation have contracted in direct proportion to the increased ease and reliability of endocardial catheter pacing, a method which carries a lower
morbidity and mortality, particularly in the aged patient.
Permanent Epicardial Pacing. The indications for
pacing by direct epicardial stimulation are: ( 1) for
temporary atrial or ventricular pacing in conjunction
with cardiac surgery for surgically induced heart block,
for the control of sinus or nodal bradycardia, improvement of cardiac output, stabilization of cardiac rhythm ,
or to overdrive and prevent or correct ventricular arrhythmias, all in conjunction with cardiac surgery. Thus
in most patients with acquired heart disease, a pacing
wire is implanted on the right atrium at the time of
surgery; (2) for control of chronic heart block in children or young adults in whom the risk of thoracotomy
is negligible. However, such patients are infrequently
seen; ( 3) if atrial synchronous pacing is being considered and thoracotomy can be tolerated, direct implantation of an atrial electrode is used, since the
pervenous techniques are not yet fully reliable; ( 4)
when transvenous endocardial pacing has not been
achieved initially or has subsequently failed, epicardial
implantation is used. It is in this category that epicardial pacing finds its most common application in
chronic heart block.
A variety of surgical procedures can be employed for
epicardial pacing. Formerly, the standard procedure
was a transpleural, left anterolateral thoracotomy, allowing access to the left ventricle and left atrium. Sec-

* Presented at the American College of Cardiology and
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ondly, the left parasternal, extrapleural approach
through the fifth and sixth costal cartilages, which exposes the midanterior right ventricule. Thirdly, the subcostal, transdiaphragmatic approach which transgresses
neither the peritoneal cavity nor the pleural space, and
which exposes the posterior right ventricle. Finally, for
the sake of complete description , there is the midsternotomy approach to the anterior right ventricle and right
atrium.
Certain technical points deserve emphasis in regard
to each of these surgical approaches: The standard anterolateral thoracotomy procedure is usually carried
out through the fifth intercostal space. We prefer to
position the patient in the full right lateral decubitus
since the left ventricle is then more easily exposed. An
excellent exposure is obtained after division of the costal cartilages. If an atrial lead is also to be implanted,
the fourth intercostal space is used. Electrode position
on the myocardium too close to the phrenic nerve may
lead to diaphragmatic stimulation. There is some disagreement regarding the proper position for the electrode. It has been suggested that more effectual contraction of the ventricle can be obtained from stimulation near the apex of the left ventricle. Others deny
this. Close to the base of the heart there is greater likelihood of damaging intramyocardial coronary arteries.
One of our p atients succumbed from ventricular fibrillation on the seventh postoperative day, and at postmortem examination one of the sutures could be seen
to encompass a significant intramyocardial coronary
artery. As a method of determining optimal electrode
position, testing to locate the position on either the left
or right heart which yields the most narrow QRS has
been suggested. We prefer the commonly employed
coil type of electrode originally designed by Chardack,
but I am very much intrigued by the electrode presented by Dr. Paul Zoll . Because of the increased susceptibility to ventricular fibrillation, a fixed-rate pacer
should no longer be considered for use with epicardial
leads in the early postoperative period. The threshold
of capture, determined with decreasing current, is recorded for future reference. After a demand or standby
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pacer has been inserted, and if the patient is in sinus
rhythm, the pacer must be converted to a fixed-rate
mode by magnet to verify the integrity of the system .
Lower thresholds are obtained with electrodes which
penetrate into the myocardium. A fl at coil epicardial
electrode, such as that used for the atrium, can also be
used on the ventricle. The late stimulating threshold is
somewhat higher, but perfectly acceptable. To avoid
the possibility of phrenic stimulation, we have usually
placed a thin layer of polyvinyl sponge between the
electrode and the pericardium. A wide loop of electrode wire is led into the mediastinum and down into
the upper abdomen. Every effort should be made to
prevent kinking of the electrode wire or flexion stress.
This concept dictates placement of the lead internal to
the costal arch and through the diaphragm, if a transpleural approach has been used. If a parasternal approach is used, the lead should traverse the subcostal
angle where motion is minimal. We have rarely used
axillary placement since the application of the above
principles in conjunction with Elgiloy (an alloy of
nickel, cobalt, and chromium) wire has completely
eliminated lead fracture . We have not favored implanting a generator behind the rectus fascia because of the
increased difficulty at the time of subsequent battery replacement. When a unipolar system is used, the
ground plate of the generator should be faced anteriorly in the subcutaneous tissue so as to avoid the possibility of muscle stimulation. The subcutaneous pocket
should be large enough to prevent tension during closure, but it should not be so large as to allow rotation
or turning of the generator unit with resulting stress on
the leads. The pocket should not be placed in the lower
abdomen, since bending at the waist will lead to increased flexion stress on the leads. The pocket is developed one-third cephalad to the transverse skin incision and two-thirds caudad to it. Absolute hemostasis
is essential to minimize the potential for infection in the
presence of a foreign body, and we make every effort
to avoid catheters or drains. When used within two
inches of the generator unit, the coagulation cautery
may cause temporary malfunction of the unit. An adequate loop of wire leads should be coiled behind the
generator to permit easy and safe extrusion of the unit
at reoperation . Antibiotics are instilled into the pocket
and used systemically for forty-eight hours postoperatively. Adherence to the above principles, together with
a very careful and accurate closure of the subcutaneous tissue with nonabsorbable interrupted sutures, has
yielded a record of no wound breakdowns in about 70
cases and only one infection, this beginning in the subcutaneous tissue. A temporary transvenous catheter is
employed in all patients with complete heart block who
must undergo general anesthesia, such as would be required for a thoracotomy procedure. This type of pacing control facilitates the epicardial implantation of the
electrode since sudden discontinuance of rapid pacing

Fig 1--Sudden discontinuance of rapid pacing achieves a
prolonged asystole and quiet heart.
achieves a prolonged asystole and quiet heart (Fig. 1) .
When an atrial surface electrode is employed with atrial
synchronous pacing, this is sutured to the epicardium
near the base of the auricular appendage.
Alternate methods of direct implantation are important and more commonly employed. As evidenced, the
transdiaphragmatic, subcostal incision, an approach
which requires general anesthesia, is well tolerated by
aged patients, providing endotracheal intubation is used
and maintained until full recovery. Through a subcostal
incision the rectus sheath is incised and the muscle retracted laterally. Some of the rectus fibers must necess:irily be detached from the costal arch. Properitoneal
fat is swept away from the undersurface of the diaphragm and an incision made in this structure to gain
entry into the pericardia! cavity. The undersurface of
the right ventricle is exposed where one or two electrodes can always be implanted in an area devoid of
epicardial fat. Three maneuvers may facilitate the exposure: the creation of an inverted flap of diaghragm
to which traction is applied; the caudad retraction of
the diaphragm; and induced paralysis of the diaphragm .
The patient with a very narrow costal angle or the very
fat individual presents difficulties with this operative
approach, and an alternative method may be more suitable. Postoperative endotracheal extubation should not
be permitted until full recovery of ventilatory function is assured, and this must be very carefully monitored in the group of elderly patients. The generator
unit is conveniently implanted subcutaneously in the
left upper quadrant. There is remarkably little pain associated with this approach and it is well tolerated by
the aged.
The left parasternal approach may sometimes be accomplished under intercostal nerve block and local infiltration anesthesia, but one should be prepared to
supplement this with general anesthesia when necessary.
After resection of the fifth and sixth costal cartilages
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and division of intercostal bundles, the pleura is retracted laterally, the pericardium incised, and one or
two electrodes implanted on the anterior midright ventricle. One surgeon has managed to accomplish this after the resection of only one costal cartilage, but he
utilizes a pacemaker catheter sutured into the right ventricular myocardium rather close to the septum.
For the sake of completeness, one should mention
the sternotomy approach to the anterior right ventricle.
This can be achieved through a complete midsternotomy or by a combined upper midline abdominal and
lower midsternotomy incision. Poor healing in the very
elderly and debilitated must be considered a drawback
to this approach.
Permanent Transvenous Endocardial Pacing. We do
not electively insert a temporary pacing catheter as a
preliminary step for this procedure. However, perhaps
30 percent of our patients have had a temporary catheter in place at the time permanent implantation is undertaken. The temporary catheter should be removed
under fluoroscopy before the conclusion of surgery
since its withdrawal may dislodge the permanent catheter when withdrawn.
The electrocardiogram should be monitored throughout the procedure and the cardiac rate and rhythm influenced by isoproterenol, lidocaine, or atropine, as
needed. All means must be available for possible resuscitation.
The external jugular, the cephalic, and the internal
veins are the available routes. The cephalic vein provides the most desirable route on theoretical grounds,
but in elderly females the vein is not infrequently
atrophic. When this route is elected, the entire surgical
procedure is carried out infraclavicular; the initial skin
incision being extended medially and inferiorly from
the deltopectoral groove for the purposes of developing the subcutaneous pocket. Reports of wire breakage, due to torsion of the leads, strengthen our opinion
that a left-sided approach to the cephalic vein provides
a better and more gentle curve for the lead. Most often
we have used the right external jugular vein. If entry
into the superior cava cannot be promptly gained, the
transverse incision is extended medially to expose the
internal jugular vein between the heads of the sternomastoid muscle. We do not ligate the internal jugular
vein, but secure the lead at the point of penetration
with several purse string sutures of nonabsorbable suture. After a short loop in the neck, the catheter is
carried subcutaneously across the medial end of the
clavicle, where there is minimal movement of the catheter with shoulder motion. We have preferred a unipolar catheter. The stylet should be gently curved at
its end to facilitate passage of the lead into the right
ventricle, but a straight stylet is used for the final positioning in the right ventricular apex. The tip of the
catheter should be wedged under the trabeculae at the
apex so that cardiac contraction causes a synchronous
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and slight buckling near the tip, but a gentle curve lies
in the right atrium without angulation. The flange on
the catheter tip serves admirably to minimize catheter
displacement, and this is now an infrequent occurrence.
The fibrous sheath developing later tends to minimize
dislodgment. Attempted forceful withdrawal at a considerably later date could cause damage to the tricuspid valve where the catheter may be adherent. If there
is any doubt about the position of the catheter in the
apex of the right ventricle, a lateral X ray should always be obtained before the procedure is terminated.
In the correct position the catheter tip lies immediately
retrosternal. A position in the coronary sinus may stimulate a correct placement as seen in the anteroposterior view, but a lateral film usually, but not always,
discloses the error. In the coronary sinus position, the
electrocardiogram reveals current activation from the
left ventricle and shows RBBB in Lead V1 rather than
LBBB. Rarely, according to Gulotta, an intracardial
electrogram is required to distinguish between an epicardial position anteriorly in the coronary sinus system
and the endocardial position at the right ventricular
apex. We have not employed this modality. These di1ficulties, however, can all be obviated if one first sweeps
the catheter tip through the right ventricle to identify
its position in the RV chamber before seeking a final
position at the apex.
Stable pacing at a low threshold should be sought;
i.e., under 2 milliamps, and repeated repositioning may
be required to achieve this. A postion in the coronary
sinus system usually, but not always, gives a high threshold. The threshold is measured with an external pacemaker. By decreasing the current after initial capture,
the point at which capture is lost determines the threshold. The threshold may be expected to increase several
fold before final stabilization.
When a satisfactory position is clearly obtained, the
vein should be securely ligated around the catheter
with several nonabsorbable sutures of the plastic variety. The emerging loop of catheter is stabilized with a
small plastic sleeve which is sutured to surrounding tissue to eliminate kinking. Additional sutures which may
be required about the leads should be of absorbable
material so that some play in the fibrous sheath which
forms will ultimately be permitted. It is essential to close
the platysma muscle in the neck to prevent the possibility of late erosion of the catheter through the overlying skin.
The pacer pocket is prepared in the infraclavicular
region. We have not favored the axillary position where
shoulder motion has been reported to cause wire fracture. In very emaciated patients, we have extended the
leads subcutaneously to the upper abdomen where
more abundant covering is usually found.
If the original implantation has been made properly,
subsequent generator changes are simple. However,
before the unit is lifted completely free of the pocket,
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the entrapped lead posteriorly should be freed from its
sheath so that withdrawal of the unit does not lead to
dislodgment of the lead farther distally, indeed, even
from the endocardium.
The implantation of pacemakers which stimulate
the atrium or synchronize from the atrium necessitates
some alteration in the techniques described above.
The indications for this generation of pacemakers
are primarily the hemodynamic advantages of the atrial
pump and the avoidance of parasystoles. It is the most
physiological responsive mode of pacing, and there
may be a gradual return to this mode by physicians
as reliability of these pacers increases. Theoretically,
this mode increases the exercise capability of the healthy individual and provides an advantage for the patient in heart failure. However, the older patient not
in heart failure should be provided with a ventricular
pacemaker. The atrial pacer is clearly not indicated
for the patient with coronary artery disease where a
controlled slow rate is to be preferred. When atrial
arrhythmias are present or develop subsequently, an
atrial synchronous pacer may well increase the difficulties of management.
The most reliable method of atrial pacing is obtained
by suturing an epicardial lead directly onto the atrium;
to the left atrium, via a left anterolateral thoracotomy,
or to the right atrium via a midsternotomy, or if only

an atrial lead is to be applied, the right anterolateral
approach. The electrode is placed near the base of the
atrial appendage. Bruck has described an approach to
the right ventricle and right atrium through the subxiphoid route, but this would seem to be both difficult
and unreliable.
Currently, the most popular route is transvenous,
usually the external jugular, for the atrial lead, with
the ventricular lead being inserted through the cephalic
vein. The straight catheter has proved unreliable; only
the J-shaped catheter against the right lateral wall or
in the atrial appendage has yielded an acceptable and
reasonably stabile atrial pickup. The position is not so
critical for atrial stimulation as for atrial pickup. Dodinot has urged that if a P-wave potential throughout
the entire atrium of 1.5 mv is not obtained , the procedure should be abandoned. A position in the appendage
is to be preferred since potentials of up to 3.0 mv may
be obtained in this position. A pacer sensitive to an input signal of .5 mv is used. Carlens and Lagergren
have described the insertion of the atrial electrode via
mediastinoscopy. The scope is inserted behind the right
pulmonary artery slightly to the left of the midline
and the lead deposited in a small area behind the left
atrium. This approach has been used infrequently or
not at all in this country. For the patient with sinoatrial arrest, an atrial pickup electrode used in con-

Fig 2-A tracing obtained by telemetry which reveals one of the problems with P-wave pacing.
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Fig 3-The phrenic nerve at the superior thoracic inlet being stimulated retrograde up the original broken lead.

junction with a sensitive demand pacer is most suitable.
I have had no personal experience with atrial catheter placement except in a few instances of temporary
atrial pacing. However, Dr. Nick Smyth of Washington,
D.C., kindly supplied me with his own personal statistics relative to his success with a special I-shaped catheter in which placement has been made in the atrial
appendage. Of 20 attempts, there were 5 failures either
because of low P-wave voltage or high threshold for
stimulation. Two of 15 initially successful cases were
not stabile and subsequently converted to ventricular
pacing. The other 13 have remained stabile.
Figure 2 is a tracing which was obtained by telemetry and it shows one of the problems with P-wave pacing. The patient was exercised until the rate rose to
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120, at which moment the blocking mechanism of the
P-wave pacer intervened and rather abruptly the rate
of the patient dropped from 120 to 50-60. As the patient rested, her intrinsic rate began to fall and the
blocking mechanism was cancelled, and her rate suddenly accelerated from 53 up into the 90's. These sudden changes in heart rate are not desirable and represent a drawback of synchronous pacing.
I wish now to present illustrations of pacemaker
problems:
A child of eight with congenital heart block had
been resuscitated several times by her father. A Pwave synchronous pacer was implanted with epicardial
leads which crossed the costal arch. Flexion creasing
was soon noted at the costal arch in this very active

TECHNIQUES AND MODES OF INSERTION

Fig 4-A direct measurement of arterial pressures before the pacer cut in.

...........

-

·~--__,,---.""'-----,;..,,-----~:--------.....----~---------1

Fig 5-At the moment the pacer cut in, blood pressure decreased abruptly 30-40mm of mercury.
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child, and subsequently breakage caused malfunction
four months after implantation. Repair was accomplished by splicing the more durable Elgiloy wire to
the broken lead, and, in addition, the leads were transposed below the costal arch and through the diaphragm. The P-wave pacer functioned well for another
year until it caused a very rapid rate and the child
died at school, an example of the so-called runaway
pacemaker.
The next case illustrates a suboptimal position of
the catheter in the right ventricle. In the lateral roentgenogram the catheter does not reach to the sternum,
but pacing continued satisfactorily for three or more
years. This position should not usually be accepted.
Occasionally the left diaphragm may be stimulated by
a catheter which penetrates partially or completely
through the right ventricular myocardium. We have
also observed stimulation of the right diaphragm by a
unique mechanism. In this case, a platinum iridium
lead over the right clavicle fractured one to two years
after its placement. A new catheter was inserted into
the right ventricle and the broken lead was cut off and
allowed to retract. From this time on, the patient
noted intermittent twitching in the right side of the
abdomen and contraction of the right diaphragm was
confirmed by fluoroscopy. The tip of the second catheter was seen to lie very close to the tip of the first
catheter. We surmised, and I believe correctly, that
the phrenic nerve at the superior thoracic inlet was
being stimulated retrograde up the original broken
lead (Fig. 3). When the generator unit is subsequently
changed, we can probably use a low output unit which
will suffice for pacing the heart without major leak of
current to the other lead.
Another case illustrates the problem of myocardial
perforation. Two months after the implantation the
catheter appeared to be in good position and was functioning well. Soon thereafter direct diaphragmatic or
left phrenic nerve stimulation was noted. One month
later a change in catheter position was noted and pacing was now intermittent. One year later stabile stimulation of the heart was occurring, but the catheter had
again changed position and the oblique roentgenogram revealed that the tip of the catheter was quite
far posteriorly, presumably in the pericardium. When
pacing ceased soon thereafter, we exposed the generator unit and measured a stimulating threshold of about
12 milliamps. A high output generator was implanted
and satisfactory pacing was reestablished.
A Ph.D. engineer sustained a myocardial infarct. A
temporary catheter was considered necessary at this
time. Six months following discharge from the hospital
he developed mild Stokes-Adams attacks due to intermittent heart block. A QRS-triggered demand pacer
was inserted. Subsequently, he developed episodes of
lightheadedness, faintness, and weakness, and he could
detect the moment at which his pacemaker took over
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functionally. He had fewer symptoms when he was
exercising and the intrinsic heart rate exceeded the demand pacer rate of 70. A direct measurement of arterial pressures was made and it was noted that at the
moment the pacer cut in, the blood pressure decreased
abruptly 30-40mm of mercury (Figs. 4 and 5) . When
the conducted rhythm returned, the pressure rose to
the preexisting level. With the patient resting the pacer
cycled in and out. An explanation for this mechanism
may be sought in the paper by Levy and Edelstein.
The above illustrations represent only a few of the
many complications of a surgical and electronic origin
associated with the art and science of pacemaking.
Many of the frustations of the past have been overcome, but each new advance also brings its problems.
Author's note: I was aided in the preparation of
this paper by Dr. David H. Sewell who at the time was
a Cardiac Surgical Fellow at the Medical College of
Virginia.
PANEL DISCUSSION

Dr. Drew: Do you in any way recommend that an
internist and general surgeon team up to implant the
permanent transvenous type pacemaker, or do you
feel that the internist should concentrate on learning
the technique of the temporary pacing catheter and
transfer the patient to the nearest medical center?
Dr. Bosher: We have different situations at the Medical
College of Virginia. Unfortunately, we do not have
a cardiologist in the X-ray department when we implant the permanent pacer; they are much too busy
with their own duties. However, at hospitals where I
have had a cardiologist work very closely with us, I
found this to be a very favorable situation. All of the
temporary catheters are now implanted by cardiologists
in our hospital, and I think this is the way it should be
because they see these patients as emergency patients.
I think the surgeon can help with the permanent implantation, but I am quite aware of the fact that
cardiologists sometimes do the permanent implantation.
Dr. Drew: Am I correct in saying that you think
permanent pacing would be better reserved for the
medical center?
Dr. Bosher: No. I think permanent pacing can be
carried out in any good hospital where you have an
interested team; that is, doctors who have familiarized
themselves with these techniques.
Dr. Drew: I think this is an interesting point, because
we do see people put into ambulances with an isoproterenol drip.
Dr. Bosher: This is very bad. Where the patient is in
this type of extreme situation, I think it is better
to have the surgeon go to the hospital rather than
have the patient go to the surgeon.

Emergency Management of Pacemaker Failure*
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The purpose of this report is to describe the more
common problems encountered with permanent
pacemakers and their management.
One of the serious recurring problems is loss of
output from the pacemaker. As a result, no pacemaker impulse whatsoever is seen on the electrocardiogram and the heart rate appears slower than
the fixed rate of the pacemaker. In such a situation,
if a patient is pacemaker dependent, whereby he will
become symptomatic without the pacemaker, a temporary pacemaker electrode must be inserted immediately as an emergency procedure. On the other
hand, if the patient can get along for a while
without the pacemaker, then the pulse generator
can be replaced electively under local anesthesia.
In taking care of any patient, it is extremely important to decide whether or not the patient is pacemaker dependent. This information must be readily
available; thus, by providing the patient with some
type of identification bracelet or by labeling the
chart with a specific tag, the patient will be treated
appropriately and without delay.
Another problem that appears frequently is change
of pacemaker rate. The most common cause for
a change in rate is the drop in output of the battery. This can usually be determined by the exclusion of two other possibilities: competition and
change in impedance. If the patient is "competing,"
the pulse at the wrist may be considerably slower
than the rate seen on the electrocardiogram. An
electrocardiogram will demonstrate whether or not
the pacemaker is behaving normally, and if the
pulse deficit is a result of an inability to palpate
early coupled beats. A change in the impedance of
the electrode, as seen when the tip of an electrode
breaks, can also change the pacemaker rate if that
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particular model is load sensitive. However, most of
the time if there is a real change in the rate, as
measured on the electrocardiogram or any suitable
interval counter, the usual cause is a drop in battery voltage and pulse generator output, which is
treated by the replacement of the unit.
A noncompetitive pacemaker firing at a fixed
rate indicates that the sensing circuit has failed .
Sensing failure causes difficulties in making a proper
diagnosis by external examination, X ray or electrocardiograms alone. Many judgments can only be
made by operating on the patient and exposing the
pulse generator and electrodes. However, an X ray,
both PA and lateral, may reveal malposition of the
electrode or perforation of the heart. There is also
the possibility that scarring has occurred in the area
of the electrode with a drop in the amplitude of
the intracardiac signal to which the pacemaker no
longer responds. With the pacemaker surgically exposed, the amplitude of the R wave and the output of the pacemaker should be measured. If pacemaker output has dropped, failure to sense has been
caused by battery exhaustion. If a new pacemaker
does not behave properly in its sensing mode, something bas happened at the electrode myocardial interface; consequently, a new electrode position must
be found or a more sensitive pacemaker implanted.
When sensing failure has occurred after the 20th month,
a safe assumption may be made that battery exhaustion
was the cause.
If a pacemaker fails to elicit a ventricular response
and the rate is the same as it was when the pacemaker was inserted, there is probably something
wrong with the electrode position. Either the electrode is dislodged or the threshold for excitation
exceeds the pacemaker output. High threshold occurs most commonly . from sepsis along the electrode, scarring of ·the myocardium, or a break in the
wire within the insulating sheet. Short circuits can
also occur, shunting ·S9me of the current away from
the heart; this is usually due to a set screw on the sur149
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face of the pacemaker that is not properly insulated,
leaving a path between the anode and the cathode.
Short circuits occur at other areas in the same way,
but most of these problems are detected on the operating table. If careful analysis reveals a problem that
can be easily corrected, such as splicing a broken wire
or repairing broken insulation, it is wrong to replace
the pacemaker.
If there is failure to capture and the rate of the
pacemaker has also changed, a safe assumption would
be that the output is down. The possibility that
something has happened to the impedance must also
become a consideration; however, the former is by
far the more common reason. Exposure of the pacemaker and testing of the threshold for stimulation and
output of the unit will solve this problem.
Runaway pacemakers, unfortunately, continue to
present a problem. In runaway cases, modern pacemakers have been constructed to ensure a simultaneous drop in output to avoid capture of the heart.
In other words, when the rate increases, the output
will fall below threshold. Removal of a runaway pacemaker is urgent even if the rate is only slightly
increased. This will help prevent further increases
that may occur within a short period of time. The
treatment for a runaway pacemaker is either rapid
incision to cut the wire, pacing on that wire, or
removal of the pacemaker from its pocket to disconnect it. The latter is preferable if time is available. Pacing can be continued with an external unit
on the same electrode, thereby preserving it; a new
pulse generator can then be implanted using the
original wire.
Pacemaker extrusion is another complication that
may be encountered. Causes of extrusion are pressure necrosis of the skin overlying the pacemaker,
acute or chronic infection and hematomas. Whatever
the mechanism, once the pacemaker erodes through
the skin, several therapeutic options can be considered. The first is not to do anything, because once
the pacemaker appears through the skin, enlargement of the hole often occurs slowly. There will be
a draining sinus that can be covered with a bandage through the full 20 to 24 months of pacemaker
life, if the patient is willing to put up with the inconvenience. Whether the unit is changed at once
or at the end of the battery life, the surgical technique for replacement is the same; an incision is
made on the opposite side, isolating the field from
the infected side. By sewing drapes to the skin after
the new pacemaker electrode is inserted, the infected unit can then be removed by a separate surgical team. Once the old pacemaker electrode has
been withdrawn, the new one is definitely positioned
and, if necessary, used for temporary pacing. When
the clean operation is finished, the wound on the
original side is drained and closed. Another option
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may be irrigation of the infected wound with antibiotics. On rare occasions, this method has been successful in aborting infection and pacemaker extrusion. Veins are always available for permanent
transvenous pacing. If the cephalic vein on one side
has been used, other veins will still be acceptable
at a later date, including the subclavian vein, or its
tributaries, and the external and internal jugular
vein.
Another troublesome complication is twitching of
the diaphragm. This is uncommon , but when present it is usually a sign of trouble; such as perforation of the heart or malposition of the epicardial
electrodes. Occasionally, a transvenous electrode may
have pulled back into the atrium where it would
stimulate the right phrenic nerve. Once in a while
the diaphragm can be stimulated through the intact
ventricle, especially if the ventricle is very thin.
All of these possibilities must be corrected by repositioning the electrode. If there are two epicardial
electrodes near the left phrenic nerve, the problem can be corrected by converting it to a unipolar system. Upon determining which electrode produces the twitch, it should be used as the indifferent electrode, using the other one as the stimulating electrode. In this way, implantation of an
entirely new system can be avoided.
There have been instances in which pacemakers
have been seen jumping back and forth in their
pockets. When these pectoral muscles near the pulse
generator twitch, some form of correction should be
made. If it is a bipolar pacemaker with both electrodes in the heart, obviously there must be a bared
wire or an uninsulated set screw. These defects
produce direct stimulation of a somatic muscle. A
break in the insulation is a more common problem,
but is often difficult to fix. The broken Silastic
sheath must be reinsulated and shifted to a unipolar system, or a new system must be installed .
Twitching in unipolar electrodes can be caused
by various other factors . There have been cases in
which an electrode has been pulled out entirely,
wrapping around the pacemaker so that the cathode
was in the subclavian vein against the pectoralis
major muscle. The pacemaker can also turn over
with the anode facing the muscle rather than the
skin. Although this does not always cause twitching,
a twitch is less likely to occur when the pacer is
plate up rather than plate down. Since a twitch can
occur in any position, it is important not to use muscle
relaxants on those occasions when general anesthesia is required during insertion of the pacemaker.
If a pacemaker has flipped over, it can be recognized by palpating the pacemaker, observing if it is
loose in the pocket and then flipping it to the proper
position. In unipolar pacing systems there are other
kinds of leaks around the electrode connector, par-
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ticularly around the Silastic collar or the set screw,
that can produce short circuit, high current density
paths to somatic muscles.
There has been some recent discussion about
electrical interference. An unusual example of this
occurred with a patient who had an external Medtronic pacemaker with a bipolar electrode in the
heart and an EKG telemeter attached to his chest.
Several times he had experienced complete asystole.
Thinking that the cause might be electrode malposition or that the pacemaker was defective, he
had been taken to the catheterization laboratory.
After trying many different external pacemakers, all
of which showed the same problem, the telemeter
was removed, revealing that the radio frequency
transmission from the telemeter had been blocking
the external pacemaker. Such interference with pacemaker function is rare, but is something to be aware
of in coronary care units. If a telemeter is used in a
patient with a pacemaker, the telemeter should be
kept far away from the pacemaker. Better still, a
different type of monitoring system should be used.
Another problem encountered is the handling of
a patient who complains of dizzy spells, yet the
electrocardiogram reveals that the pacemaker is functioning normally. To decide what is the problem,
a series of exclusions must be considered. Is the
output of the pacemaker dropping? This is likely if
the pacemaker is 22 months old and there is also

a change in rate. Is there a high threshold so that
pacemaker output is just borderline? Is there intermittent malposition of the electrode? This is difficult
to diagnose, but often can be suspected by the X-ray
configuration of the leads. Is there intermittent contact of a broken wire within its insulation? Does the
patient have intermittent bursts of ventricular arrhythmias? This must be suspected if in a long
rhythm strip frequent ventricular premature contractions are seen.
"Pacemaker syndrome" is still another area that
causes problems. This is characterized by the symptomatic fluctuation of the blood pressure, usually
in a patient with a fixed-rate pacemaker, from atrial
and ventricular asynchrony. The diagnosis can be
confirmed only by ruling out all other causes of
weakness and by recording wide blood pressure
fluctuations. What about electromagnetic interference? Did the patient do anything unusual preceding
the weak spells? When all of these ruminations have
been considered and all causes of weakness have
been discarded, it must be assumed that the patient
is right; something is wrong with his pacemaker
system. If you cannot make a definitive diagnosis,
the pacemaker should be exposed and its output
and excitation threshold should be tested. Nine times
out of ten, the patient is right and it is necessary to
adjust the pacemaker.
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Pacemaker longevity is a serious problem to overcome. However, our immediate concern is to get as
much useful life from a pacemaker as possible. On the
average, pacemakers fail in about 23 months. The only
pacemaker that lasted much longer was a fixed-rate
unit, the Medtronic 5860, which is no longer available.
A past suggestion in handling this problem has been to
change the pacemaker electively at an arbitrary time,
but that time has varied tremendously as the manufacturers once selected 30 months, and more recently
15 months. If a pacemaker is replaced at 15 months,
very few of them will actually be near the end of their
life span.
For those who like to experiment, there are several
kinds of pacemakers available. Presently, we have
used 33 different models from eight manufacturers
with varying pacing modes. Pacemakers can be fixed
rate, atrial synchronous or noncompetitive; bifocal and
cyclic; or attached to unipolar or bipolar electrodes.
Electrodes have been situated in the myocardium or
endocardium, using a variety of testing devices.
Because of the importance of replacing pacemakers
as late as possible, the study of the electrical output of
the pacemaker has begun in a pacemaker clinic. A
pacemaker impulse has certain definable characteristics: its amplitude can be measured at its leading edge,
trailing edge, and halfway between; and the electrical
impulse has width or pulse duration, measured from
the leading edge to the trailing edge, displaying a typical configuration (Fig. 1). A sensitive index of pacemaker function is the repetition rate or pulse interval.
Hopefully, if a comparison in pacemaker impulse is
made between its appearance at 4 months, which is the
best time to establish a base line, and its appearance at
22 months, the following changes may be noted: the
amplitude decreases, the pulse width shortens, but the
configuration remains about the same (Fig. 2).
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Fig I-Examples of pulse generator impulses (schematic)
as seen on the oscilloscope. Measurements of A, B, C,
and D are made and recorded for sequential comparisons.
Impulses 1 and 4 seen commonly with Medtronic pacemakers; impulse 3 with Electrodyne; impulses 1, 2, and
5 with Cordis; impulse 4 with American Optical; impulses
2 and 4 with Vitatron; impulse 4 with General Electric.

Fig 2-Typical changes in pacemaker impulse over 18month period.
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PACEMAKER CLINIC
Laboratory tests have produced a study of American
pacemaker models. Our engineers, working in conjunction with engineers from each company, evaluated the
behavior of each pacemaker on the bench as a number
of battery cells varied. This study showed that some
pacemakers cease to function where one cell fails,
but most others cut off after at least two of the five
cells have been lost. The drop of pulse generator output is related to the number of functioning cells and
varies from unit to unit, and the output of the pulse
generator is directly related to the number of cells and
also to the resistive load. The amplitude changes with
the load and so does the pulse width. Pulse duration
also varies with the number of cells. In some pacemakers, the pulse width will widen as the number of
cells change; in others, the pulse width will shorten.
Pulse width is also affected by the load.
Pacemaker sensing circuits also have a failure threshold. As the number of cells are reduced, the sensing
circuits begin to fail. In most pacemakers, the sensing
circuit will fail before there is a loss of output from
the pulse generator. The sensing circuit of the American
Optical pacemaker, however, will continue to function
well into late pacemaker life. This parameter can be
measured and tested in the clinic.
In evaluation of the pulse interval, it seems preferable, although there is no general agreement on this,
that a pacemaker should slow down as the number of
cells decrease. If the pacemaker stops when it is going
slowly, idioventricular rhythm will start fairly soon
after the last effective beat. If the pacemaker speeds up
as it fails and then stops entirely, there will be a rather
prolonged period of asystole before spontaneous cardiac
action resumes. Although most new pacemakers are
designed to slow down as batteries are exhausted, actual
performance varies considerably. The number of cells
is not the only thing that will affect the rate; change
in resistive load also affects the rate with considerable
variation from model to model. All things considered,
clinical evaluation of this pacemaker problem is rather
complex. There is some doubt as to whether the resistive load has changed from minute fractures in a lead
wire or electrode corrosion, or whether the batteries
are gradually becoming exhausted.
Within the physical set up of our clinic, there are
five examination rooms in which various test devices
are connected to the patient by an electrocardiograpbic
cable attached to the limbs. Here lead I of the electrocardiogram is taken, also a "P" lead in which one
electrode is on the left arm and the other over the
pulse generator. Lead I is used to record a rhythm
strip. The P lead is used for evaluation of the amplitude of the electrical impulse. The amplitude of the
impulse depends upon the relative position of the
stimulating and exploring electrodes. Therefore, it is
of great importance to eliminate all factors that will
affect the positioning. Hence, this examination must

be performed with the patient in the same position
at each visit, using the same exploring electrodes.
In the testing room there is a computer and peripheral equipment. A monitor is used to observe the
electrocardiogram during the test process. The output
of an amplifier goes to an interval counter and to an
oscilloscope where the wave shape is photographed and
the amplitude and pulse width are measured. An electrocardiogram is also taken. All this information is then
inserted into a computer which types a report, via the
peripheral equipment, displaying the rhythm strip, a
picture of the wave form, and the doctor's comments.
Within seconds, the entire history of the particular
pacemaker under test can be seen.
Patients come to the clinic every four months for the
first year; every two months for the next six months;
and every month after eighteen months. It is quite
important that the patient be emotionally reinforced
during his visits to the clinic. Great care is taken
during the examination to provide the kind of emotional attention and support that he really needs. As
a result, the patient likes the clinical atmosphere and
will appear for further visits.
For patients who find it difficult to come to the
clinic because of infirmity, age, or distance from the
hospital, a telephone system bas been devised. This
system is used to count only pacemaker pulse rate. The
patient bolds an electrode in his left band and puts the
other electrode against the pacemaker with his right
hand. There is a magnet in the electrode which turns
the pacemaker to its fixed-rate mode. At the hospital
our technician places the phone in a cradle, and then
records the rate to within 1/lOth of a millisecond accuracy on a digital counter.
There is an advantage of not only counting the electrical impulse, but also counting the physical pulse at
the fingertips. A click is beard for the electrical impulse and a musical note for the physical pulse, enabling
the physician or technician to tell whether one follows
the other. This method bas proven to be quite valuable
as adjunct to the clinic. Of 89 cases where a satisfactory analysis could be made, interval change occurred as a sign of failure in 67; interval change alone
occurred in only 14 cases. In the great majority of cases,
the interval changed simultaneously with another parameter. Therefore, the total analysis gives somewhat
more information than measuring the pulse interval
alone.
This test may seem to be complicated, but the entire
procedure takes exactly three minutes to perform; the
patient can actually go through the whole process in
about five minutes. In New Jersey there is now a network of these clinics, all working in identical fashion.
There are also nine affiliated centers, and five or six
others waiting to join. At each center the evaluations
are done in the same way, including the telephone communication . Each center communicates by telephone
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with the computer at the Beth Israel Medical Center and
then receives a typed report immediately at their own
hospital.
There are many potential advantages to this system.
Within one year there will be 1500 pacemaker histories
in the computer in New Jersey alone. A physician will
be able to know very quickly the actual behavior of a
large sample of many different kinds of pacemakers.
If a physician decides to use X pacemaker for the first
time and something goes wrong with it, the computer
system will provide data on the behavior of 30 other
X units inserted by other physicians in the state to
which the pacemaker in question can be compared.
However, the computer is not a doctor and does not
replace good clinical acumen. A careful office examination by a doctor, in which the rate is accurately measured and an evaluation of the rhythm strip made correctly, will provide enough information to determine if
things are grossly wrong.
Until recently, these were the considerations in replacing a pacemaker. If in one month there was a
certain change of rate within 10 milliseconds (not
readily detectable by taking a peripheral pulse), or if
there was a change in the pulse duration or amplitude
(also not detectable at all by examination), the patient
would be reevaluated within a few weeks. If any two
of these changes occurred simultaneously or if the
sensing circuit failed, the pacemaker would be replaced
immediately.
In 1970, 318 patients were studied and 126 pacemakers replaced. Forty of these replacements could not
be evaluated in the clinic because replacement was for
reasons other than battery exhaustion. For example, 7
pacemakers were changed because they were extruding; several pacemakers were replaced because some
patients did not want to wait; others were changed
because patients did not come to the clinic often
enough. Other instances involved pacemakers with high
thresholds, runaway rates, plug corrosion, and broken
insulation. Of 87 that were suitable for analysis, 76
(87%) were removed electively with only 13% having
errors. These errors occurred for several reasons: nine
were actually new pacemakers and not much was
known about their behavior; three were cases in which
the change seen was underestimated; several patients
missed crucial visits; three cases were without clues
whatsoever. Some of these cases were due to sudden
failures of a component that were not detectable.
The results from the clinic in comparison to the
bench tests revealed, pulse duration the one exception,
that bench tests corresponded to what was actually
observed in the clinic. Because the bench analysis has
proven so helpful, in the future whenever a new model
pacemaker is introduced, it will be tested to provide
some idea of what the performance will be in its failure
mode.
In conclusion, the clinical approach to pacemaker
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evaluation is important because it is at least 90 % accurate. Hopefully in the near future , with the accumlation of accurate data to rely on, computers will be used
to a greater degree in aiding the diagnosis of pacemaker
malfunction: the computer will "remember" how things
ought to be and will tell when things are wrong, suggesting when the pacemaker should be changed. However, it is hoped to soon have pacemakers that will
operate reliably for ten years. Elective replacement at
nine years will then be feasible and frequent clinic tests
will no longer be required.

PANEL DISCUSSION

Questioner: What would be the indication for using
a low voltage pacemaker?
Dr. Parsonnet: Pacemakers are made with a rather
sizeable leeway between the anticipated threshold
and its output. Presumably, if you can use or have a
lower output, you can get the pacemaker to last longer.
An alternative would be to use a fewer number of
batteries, thus making a smaller pacemaker. The Cordis
people have experimented with this idea, and I am
sure other companies will do the same. As a matter
of fact, the Medtronic company tried to do the same
thing by having a potentiometer on it; you just turned
your output down and caused a decrease of a drain
on the battery. Because of this substantial decrease,
we are planning to go back to this method soon.
Questioner: Why haven't they implanted a set of
batteries in parallel elsewhere in the body to take over
when and if the other batteries fail?
Mr. Berkovits: Because most of the problems in
batteries involve short life, the extra set may fail as
quickly as the first set. There are many battery failures
that are unrelated to exhaustion.
Dr. Drew: Do any of the companies make any financial
adj ustments if the pacemakers go out prematurely?
Mr. Berkovits: To my knowledge, all manufacturers
in the United States are giving some credit for pacemakers returned with premature exhaustion.
Questioner: How accurate is the phone monitor?
Dr. Parsonnet: It is accurate to a tenth of a millisecond for the interval counter, which just measures
pulse interval.
Questioner: Have you used the transmission of a
rhythm strip to give you the intervals?
Dr. Parsonnet: No, we have not. Although it would
give you some information, it would not give you
quite enough. You would have to count the rate on
an electrocardiograph which has a sizable error in
paper speed, 2 to 3 percent, I think. It will tell you
whether or not the pacemaker is capturing the heart,
but there are other ways to find that out.

PACEMAKER CLINIC
Dr. Drew: Do you predict that other states will have
to follow suit as the number of pacemakers grows,
in order to have the type of follow-up that you have
in New Jersey?
Dr. Parsonnet: Perhaps a modification of it. I am not
quite certain what the phone is going to bring. Right
now, at least for my purpose, it is an ancillary test
procedure which is helpful but not sufficiently diagnostic. I think every patient with a pacemaker should
go to some kind of an evaluation clinic. He should
be going either to a doctor who sees him regularly
or to a center with a group of patients.
Dr. Tarjan: There is a company in Philadelphia that
follows these people with pacemakers. I would imagine
that their methods of evaluation are somewhat similar.
Should a doctor entrust his patients' care to this sort
of an organization?
Dr. Parsonnet: I do not know if there is anything
wrong with the organization. Personally, I would
rather test the rate myself. I don't trust myself half
the time, but I do trust myself more than I would a
company located elsewhere. The reason we use the
system I showed you today is because we have control over it ; we can count the rate with our own
technicians, and if something doesn't look right, we
can run downstairs and see what the matter is. With
the Pacer Tracer company, which is the one you
referred to, they count the pulse at the fingertip and
the rate, and call you on the phone. It is that middle

man that makes me a little uncomfortable. They have
a clever system and I don't want to knock them in
any way; it may turn out to be a good idea.
Questioner: How do you prepare a patient for surgery
with a pacemaker, where cautery is needed?
Dr. Parsonnet: The danger is having the ground plate
of the cautery near the pacemaker, and the active
end of the cautery directly across from it. If you are
going to do a transurethral resection, it is best if
your pacemaker is up in the infraclavicular area. Be
sure the patient is sitting on the ground plate and that
you are monitoring the heart. Because the cautery
causes interference, monitor the pulse manually. The
only precaution necessary is that you don't have a
direct line across the pacemaker. Although other
opinions may vary, we do not restrict the surgeon
in any other way; we just tell them that we will be
around in case they need any help.
Dr. Drew: What restrictions are on the patient if
they should decide to go for ultrasound treatment
on the back?
Dr. Parsonnet: Tell them to avoid diathermy, ultrasound, and everything else. We have had only two
instances of interference in our patients; both in the
early days of pacemakers when adequate protection
was not provided. Nevertheless, there has to be a
delicate balance between warning the patients and
scaring them.
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His Bundle Recordings*
ONKAR S. NARULA, M.D.

Division of Cardiovascular Disease, Department of Internal Medicine,
Mount Sinai Hospital, Miami Beach, Florida

When we record atrial activity on the His bundle
electrogram we are recording from the area of the
atrium which is around the tricuspid valve, that is,
the lower part of the right atrium. The normal range
of conduction time from the region of the sinus node
to the low right atrium is about 25 to 45 milliseconds.
When we are at the A-V junction we can record the
local atrial activity, the His bundle potentials, and
the ventricular activation. Normally, we record this
simultaneously with three surface EKG leads. We
are using this technique for quantitative measurements,
because it enables us to know where the P wave and
the QRS complex begins, and depending upon what
EKG lead you chose, it could vary the onset of these
complexes. The three leads are Lead 1, AVF, and
Vl, which give us the three plains combination :
frontal, sagital, and horizontal. A breakdown of the
PR intervals which we measure are: ( 1) the PA,
or the intra-atrial conduction from the sinus node
down to the low right atrium; (2) the AH, or the
atrial activation to the His bundle and represents conduction through the A-V node (a normal range for this
time in our laboratory is 50 to 120 milliseconds); and
(3) the HV, which is measured from the beginning of
the His bundle to the earliest ventricular activation
seen either on the EKG or on the bipolar electrogram.
In our laboratory the normal values for this are about
35 to 45 milliseconds. The His bundle deflection per
se, is about 15 to 20 milliseconds in duration, indicating how long it takes for the impulse to go through
the main His bundle before it bifurcates.
Up to now it has been taught that the left bundle
activates the myocardium earlier than the right bundle
branch or that the septum gets activated earlier from
the left side than the right. The present data which
we have collected by recording from both right and
left heart in man as well as from original experimental
work done by Hoffman's laboratory and by Rosen in a
Chicago laboratory indicates that impulse arrives at
the terminals of the left and the right bundle branches
at the same time. Also, the anterior and posterior
divisions of the left bundle receive the impulse at

* Presented at the American College of Cardiology and
the Medical College of Virginia Cardiac Pacing Symposium, April 16 and 17, 1971, Williamsburg, Virginia.
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the same time. This means that if we were to damage
one bundle branch, there should be no delay in the
impulse arrival to the ventricle. Thus it would follow
that if we have a unilateral bundle branch block the
HV time should not increase. It is considered now that
we have three branches : the main right bundle
and two divisions of the left. Therefore, if we
were to damage either of the two of these three,
we still should have normal HV time because the undamaged branch would take the impulse to the ventricle without any delay. We found clinical evidence
to support this new data when we studied about 29
patients who had left axis deviation with a narrow
QRS complex yet maintained normal HV time. There
were also indications that if we produced rate-dependent right bundle branch block through atrial
pacing, the HV time would not change. In one patient atrial pacing was done at a rate of 150 beats
per minute. This produced second-degree Wenckebach
type of block at the A-V node and right bundle branch
block. The QRS complex following the blocked P
wave was narrow. The H-V time in this beat with
a narrow QRS complex was the same as in the following beat which showed right bundle branch block. In
studies of the left side, the same phenomena was observed. We had a patient who had a rate-dependent
left bundle branch block and the HV time did not
change when the QRS complex changed from narrow
to left bundle.
Further, we have studied about 25 to 30 patients
with pure right bundle branch block. Up to this time
the feeling was that most of the patients with right
bundle branch block should have a normal HV time.
But 20 percent of the patients with pure right bundle
branch block show abnormal HV time. This indicates
that these patients have additional disease either in the
main stem His bundle or in the left main bundle or its
two subdivisions. This would explain why statistically
70 percent of patients with right bundle, left axis
deviation show abnormal HV time. They are presumed
to have additional disease elsewhere. Since this is not
reflected in the EKG, what we see is the dominant
one-bundle lesion which is the most diseased one.
For years it has been said that whenever you see a
combination of first-degree block and right bundle
branch block, it indicates bilateral bundle branch
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block. But this is not always the case. The major
delay which produces first-degree block occurs in the
A-V node, not in the His-Purkinje system. Patients
may have additional disease in the Purkinje system,
but the major part comes from the delay in the A-V
node. So first-degree right bundle doesn't always mean
bilateral bundle branch block. The only way to validate the His bundle potential is by His bundle stimulation . Right bundle deflections look like His bundle,
and there is no way to differentiate these except by
this means. This is very important when we are making quantitative analysis and diagnosis, because if
you have a wrong deflection the diagnosis is worthless.
We studied a patient who for several years had right
bundle branch block and a normal PR. On the day of
admission, he showed 2: 1 A-V block with right bundle
branch block. That evening he showed a transient
episode of complete heart block, and again the QRS
complex showed right bundle branch block. The EKG
made us suspect that the block was occurring somewhere in the A-V node, because the complex was
identical and the patient had only right bundle without
any axis deviation. When we studied him four days
afterwards, he was showing 2: 1 A-V block, the same
as when he was admitted. On the EKG, every P wave
was blocked beyond the His bundle deflection, and
the conduction time through the A-V node, that is the
AH time, was completely normal-60 milliseconds. In
the beats which were conducted, the HV time was prolonged at 85 milliseconds. The His bundle deflection
was about 35 milliseconds. What was happening was

that the lesion which produced the block was in the
main stem His bundle. Unfortunately, His bundle has
been ignored for a long time as far as lesions are concerned because they do not show anything on the
EKG. And for that reason some people have never
made a diagnosis of His bundle blocks. But if right
and left bundle produce lesions, why should the His
bundle be immune to pathology since it is the same
tissue. I believe about 40 percent of the patients with
bundle branch lesions have disease in the main stem
His bundle, and I think that as we collect more data
we will be able to stress this.
We have studied about 90 patients with right
bundle branch block, left axis deviation. As I suggested earlier, if there is a lesion in either of the two
divisions the HV time theoretically should be normal.
His bundle records in a patient with right bundle,
left axis and normal PR showed a normal HV time
of 40 milliseconds. In another patient under the same
conditions we observed the HV time at 75 milliseconds. This indicates that these patients are not a
homogeneous group and may explain why some patients with right bundle, left axis have gone for ten
years without an A-V block and some develop it
within a year. It follows that some of them have a
significant disease which is not reflected in the EKG's
and others have no disease in the third division .
We have observed that when the H-V time is abnormal, the third division is damaged. A patient came
to the E.R. with second-degree A-V block. We brought
him to the cath lab with 1 : 1 conduction and at that
time the first beat on the surface EKG showed right
bundle, left axis deviation. The His recording revealed
an abnormal H-V time of 75 milliseconds which indicated that we should expect disease elsewhere in the
conduction system. Our expectations were corroborated when the EKG spontaneously showed us right
bundle, right axis deviation in the next two beats.
We have studied 25 patients with right bundle
branch block, right axis deviation, and all of them
except one showed abnormal HV times. Statistically
this indicates that in patients with right bundle, right
axis deviation the posterior division is damaged and
there is additional disease which extensively involves
the main His bundle or the anterior division.
PANEL DISCUSSION
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Fig I-Illustration of His bundle block.
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Questioner: Dr. Narula, did I understand you to say
that the majority of patients with right bundle, left
axis had abnormal HV times, and does this mean
that they have disease here more than the right
bundle itself?
Dr. Narula: Clinically, it is felt from the EKG pattern that right bundle, left axis deviation means right
bundle branch block and damage of the anterior
division. Right bundle branch block with right axis
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deviation means damage in the right bundle and
the posterior division. This is what has been proposed
by Rosenbaum, and theoretically it is right. In reality
this is not always true, however. It is misleading to
assume from the surface EKG pattern that a right
bundle, left axis deviation indicates that a third division, i.e. the posterior division , is okay. Seventy percent of these patients have additional disease elsewhere, and probably in the posterior division itself,
which we can't see from the EKG. The right bundle,
right axis theoretically could be normal, but statistically this is unlikely, and the majority of the patients
have additional disease elsewhere involving either the
anterior division or the main stem His bundle. Just
to reemphasize that point again: there are three divisions. If disease is present in only two of the three
divisions, the HV time should be normal. Ninety-five
percent of the patients with right bundle, right axis
have abnormal HV time ; therefore, disease is probably present in the third division as well, despite the
fact that the EKG doesn't show it.
Questioner: Are you giving pacemakers to patients
who are asymptomatic but the EKG shows right
bundle, left axis deviation?
Dr. Narula: As yet, we do not make a decision to
implant a pacemaker based on His bundle recordings.
We rely instead on the clinical symptoms the patient
is having, a history of syncope, and an abnormal HV
time. Some day I hope we will have enough data to
show that patients with abnormal HV time develop
complete heart block in three years. Then we can
give pacemakers prophylactically.
Dr. Samet: What if we have a patient with right
bundle, left axis, right bundle, right axis and a normal heart rate, and he has a syncopal episode? Can
we automatically assume that his syncopal episode is
related to his conduction disturbance? We have had
at least two patients with right bundle, left axis and
one patient with right bundle, right axis who have come
in with syncopal episodes and the referring physician
was pressing for the insertion of a pacemaker. In
these three cases, His bundle study revealed a normal HV time, but in none of them was a pacemaker
implanted on this basis. We think this is a correct
decision and we are following this approach now.
Dr. Dreifus: I think that what Dr. Samet said is right.
The patient should have symptoms before you put in
the pacemaker whether it is first-, second-, third-, or
fourth-degree A-V block. Lenegre did a good deal of
anatomic studies, and he makes it clear that it doesn't
make much difference whether block is above or below. It is the importance of the symptoms based on
block. There are many patients walking around with
high-grade block in which there is no conduction from
atria to ventricle who do not have symptoms. The
minute symptoms develop and block is present, then
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I think it is time to put in pacemakers. If you do not
prove block is the cause of the symptoms the decision
rests on a clinical diagnosis. I think there are other
ways to prove whether the symptoms are due to block.
You can use exercise stress tests, drugs, or tape recordings, and a number of these patients will show
intermittent periods of nonconducted beats. Then
the decision whether or not to implant a pacemaker
can be made on that basis.
Dr. Narula: I just want to clarify a point. Dr. Dreifus
just said that you can stress the conduction system to
bring out the block whether by drugs or by exercise.
The His-Purkinje system is so immune to some of
these stresses that if you were to increase the rate by
pacing or by giving atropine, the majority of these
patients would still conduct 1 : 1, despite severely prolonged HV time. For some strange reason it acts in
such a capacity that either it conducts or it doesn't,
so that neither atrial pacing nor drugs will stress the
system. When patients with 1 : 1 conduction do develop
second-degree A-V block at high atrial pacing rates,
it almost always occurs in the A-V node. Only a few
cases develop block distal to the His bundle with increase in atrial rate and most of these latter cases
even spontaneously manifest second-degree block. The
degree of block in the patient with His-Purkinje
system lesions will increase, but if he has 1 : 1 conduction it usually doesn't. We have had patients who
came to the E.R. with complete heart block. We
brought them to the cath lab, put in a temporary
pacemaker, and within two hours we were able to pace
them 1: 1 up to 160, and they had HV times of 75
milliseconds. So I think atrial pacing might be misleading in checking the condition of the conduction
system.
Questioner: Dr. Narula, regarding control of the HV
interval which you have been placing so much reliance
on. Have you studied the same patient a number of
times, knowing what the previous HV interval was, so
that you could understand what variance you are
getting?
Dr. Narula: We had follow-up studies on the patients
with normal conduction times and also on the patients
with abnormal ones. For some strange reason the HV
interval seems to be exactly reproducible, but not the
AH. The AH interval varies from sitting to sitting, and
from time to time you recatheterize the patient. But
the HV is the same whether you recatheterize them a
week or a month afterwards. We have studied at least
100 patients in this length of time where the purpose
was to observe the progress of disease. The majority
of them have not shown even a 5 millisecond change
as yet. So the test, as far as HV is concerned is reproducible, provided you validate that the His bundle
is what you are recording.

Techniques of Bedside Pacing*
LEONA RD S. DREIFUS, M .D.

Research Associate Professor of Physiology and Biophysics, Hahnemann
Medical College and Hospital, Philadelphia, Pennsylvania

In temporary pacing the primary approach is transvenous-either percutaneous or via a cutdown in the
jugular or brachia! vein system. Tripolar and quadripolar pacemaker catheters which have been used for
His bundle recordings are now obtainable as well as
the bipolar variety. Among the latter is the floating
catheter which may also be used as an intracavitary
electrocardiogram. Doctor Furman of New York City
has been extremely successful with this type in approximately 500 patients.
The problem with the floating catheter is the potential hazard of displacement. Thus, it may be worthwhile to consider using a stiffer or semi-floating catheter. Remember that the catheter may have to remain
in place for as long as three or four days, and you
want to be sure that you can depend on it to stay in
position. One type of semi-floating catheter has a slight
bend at the end. It is much more likely to remain
securely in the trabeculae of the right ventricle, and
it may be passed blindly when image intensification is
not available.
The rigid bipolar catheter is too large for the percutaneous route and a cutdown must be perfomed
through an invasion either in the external, internal
jugular or brachia! vein. But if you want to save yourself a lot of time and trouble in making these temporary pacemakers remain in place you may have to
use this kind. There is one type of rigid catheter on
which the electrodes are located 15cm from the tip. It
is softer than the other rigid catheters, and it is to be
inserted into the pulmonary artery so that right ventricular outflow pacing is possible. Figure 1 shows the
electrodes in the outflow tract of the right ventricle and
the tip in the right pulmonary artery. The importance
of this type of catheter in addition to the position of
the electrodes is its softness which doesn't irritate the
ventricle. We have had a number of cases of ventricular
fibrillation during catheter placement in the apex of the
right ventricle in patients with an acute myocardial infarction. We have defibrillated them calmly during the

* Presented at the American College of Cardiology and
the Medical College of Virginia Cardiac Pacing Symposium, April 16 and 17, 1971, Williamsburg, Virginia.
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Fig 1-Catheter electrodes in the outflow tract of the
right ventricle and the catheter tip in the right pulmonary
artery.

Fig. 2-Percutaneous catheter needle on point of insertion
at mid clavicle at a 45 degree angle.
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catheterization, but this is always a risk, and a bolus of
lidocaine lOOmg is administered intravenously prior to
the insertion in patients with this condition. This prophylactic measure results in less ectopic beats and runs
of ventricular tachycardia, and I would recommend it in
such patients in order to avoid serious ventricular
rhythms.
When using percutaneous catheters it is important
to select a needle with a good 13-gauge lumen in
order to pass the catheter. Percutaneous pacemaker
catheters may be inserted at mid clavicle at a 45 degree
angle as shown (Fig. 2) or above or below the clavicle.
The problem in approaching the subclavian vein is that
you really have to fish for it. But any third-year medical
student can accomplish this, and fortunately you can
get into the vein blindly. The catheter can then be
placed down into the superior vena cava, right atrium,
and on into the ventricle. In addition to catheter placement in the outflow tract of the right ventricle it is
possible to pace from the apex, the right atrium, and
the coronary sinus. Usually you can document the position of the catheter by attaching the external lead
to the electrocardiogram and observing the electrocardiographic changes. It must be remembered, however, that if the electrode is touched in an ungrounded
situation ventricular fibrillation may occur with the intracavitary electrode technique. Therefore, the use of
image intensification is preferred.
I invariably use demand pacing particularly in patients with recent myocardial infarction to avoid competition. An exception to demand pacing during an
infarction would be the use of overdrive pacing for
ventricular tachycardia.
There are several types of pulse generators, and you
may make your own if you like. However, to provide
effective pacing rates for atrioventricular sequential
pacing, rapid atrial stimulation, and paired pacing you
have to use a coupled pulse generator (Fig. 3).
Coupled or SS. paired pacing is a bedside technique
that I would not recommend in ventricular pacing unless you have a computer that has measured the cycle
length ahead and programmed the next S,S2 interval.
Otherwise, ventricular fibrillation will very likely occur.
Paired pacing of the atria in cases where atrial tachycardia are uncontrollable by any other means can be
used to reduce the rate by one half. The problem with
ventricular pacing is that there is only one pulse in
the brachia! artery for every two electrical stimuli and
this may cause a decrease in the stroke volume which
could lead to acute pulmonary edema.
Dr. Philip Samet's approach of rapid atrial stimulation as a means of converting atrial arrhythmias is of
value in the digitalized or over-digitalized patient in
whom electrical countershock may not be feasible.
Additional indications for rapid atrial stimulation are
recurrent atrial tachycardia or flutter particularly during an acute myocardial infarction as well as during
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Fig 3-A coupled pulse generator.

cardiac catheterization when transient arrhythmias may
result in changes in the oxygen determinations. The restoration of normal sinus rhythm would then allow one
to obtain more reliable data. The use of rapid atrial
stimulation also avoids the need for administration of
an anesthetic.
One indication for the use of temporary pacing is
premature ventricular beats in the presence of a prolonged QT interval. The use of drugs would further
prolong the QT interval and increase the opportunity
for ventricular tachycardia. I would also recommend
pacing in patients with acute myocardial infarction and
in patients with high-degree A-V block associated with
ventricular tachycardia. In these instances overdrive
pacing as a bedside technique has worked very well.
Aµother indication for temporary pacing is reentry
atrial tachycardia in patients with Wolff-ParkinsonWhite syndrome. I would recommend, however, that
pacing not be performed in patients with WPW as a
means of converting atrial flutter or fibrillation or to
induce these arrhythmias in patients with this condition. As Dr. Neil Moore has demonstrated so beautifully, you may buzz or overdrive the atria to the point
of ventricular fibrillation.

TECHNIQUES OF BEDSIDE PACING
Figure 4 shows an example of a six-week-old child
with paroxysmal atrial tachycardia in which overdrive
pacing was used. The electrocardiogram shows delta
waves during sinus rhythm and is termed the type A
form of WPW syndrome. A floating catheter was
placed and the rhythm converted by atrial pacing.
The child was managed with a radio frequency pacemaker on a permanent basis. The aerial of the transmitter was placed over the heart and sinus rhythm
was then reestablished each time. The child's mother
learned to stop the tachycardia by broadcasting the
pacing at borne.
Ingenuity is an important requirement in using any
of the above bedside techniques because many problems
will have to be solved on the spur of the moment.
You should be knowledgeable about these techniques
and have all the equipment around you so that you
will have a system you can depend on.

Fig 4-Type A form of Wolff-Parkinson-White syndrome
complicated by PAT.

PANEL DISCUSSION

Questioner: Dr. Dreifus, what are your criteria for
a floating catheter versus a rigid catheter?
Dr. Dreifus: I would use a floating catheter in the
extreme emergency. I would go to the rigid or semirigid ones if I bad a little more time to make decisions. Then I would use image intensification to
get the catheter into the trabeculae, making sure it
is well placed and that the threshold is adequate and
low enough so that both sensing and pacing are possible. If you lose the sensing part, you then have a
fixed-rate pacemaker, which will not sense premature
beats and will give you a new impulse on top of a
T wave. Premature ventricular beats with an acute
infarction could be dangerous, so it is imperative
that you get the best position so that the catheter
doesn't slip out. You may need it in there for a week,
two weeks, three weeks, four weeks, sometimes. I
know Dr. Furman used to put them in for a year
back in 1959 or so, and they remained in place and
patients stayed alive because of these rigid catheters.
But if I had my choice, I would choose a rigid one,
and I would spend some time getting it into position
with plenty of antiseptics so I wouldn't get infection.
Dr. Parsonnet: May I make one comment about the
rigid catheters? We have some interest in them since
the one you are talking about was designed by Dr.
Zucker at our hospital and is sometimes called a
Zucker catheter. We are not cutting down any longer
on those. We are putting them in through the subclavian vein with a needle, and we pass a rather large
sheath over the needle and then pass the catheter
through the sheath. But we also feel quite strongly
about the statement you've already made, Leonard,
that these electrodes should be fixed and placed with
anatomical control using fluoroscopy and not with the
free-floating technique unless you are in a terrible
hurry and unable to obtain bedside fluoroscopy.
Dr. Zoll: Dr. Dreifus has made a point of great importance and I want to take this opportunity to say
that I agree with it. I think it is extremely important
to use demand pacemakers in patients with acute
myocardial infarction. The risk of repetitive response
in fibrillation is a very serious one-indeed, so serious that I try not to use catheters at all in these
circumstances. But if you are going to use one, for
goodness sakes, make it a demand. In this regard, I
should point out that although it seems difficult in
Philadelphia, and perhaps in other places, in some
areas one finds that emergency control can be accomplished readily. While you are preparing to move
the patient or the bedside X-ray machine, you can
manage the situation possibly with external electric
stimulation and by intravenous drug therapy with
epinephrine or isoproterenol. Most of the time it is a
matter really of only a minute or so to control rhythm
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with intravenous drug therapy. You can arouse a
ventricular pacemaker, you can accelerate it, you can
overdrive ectopic activity, and you can gain control
very often with drugs, but then you are not in such
a desperate hurry to get the catheter in place.
Dr. Baird: How reliable is demand pacing in a temporary situation as far as over-sensing or undersensing either with the temporary floating, semi-floating, or stiff catheter electrode systems?
Mr. Berkovits: For temporary pacing you must have
the electrode placed as well as you would for permanent pacing, because detection of the endocardial
depolarization depends on proper electrode placement.
You must have an endocardial signal to control the
demand pacemaker, otherwise you don't have a demand pacemaker. The endocardial signal of the floating electrodes is not acceptable and will not be reliable
for controlling demand pacing.
Dr. Samet: I would like to add something here. Anyone who is trained in catheterization can pass at least
three quarters of the rigid catheters into the right
ventricle blindly just by repeated manipulation. You
won't be in an ideal position, but you will be in a
reasonable position to capture the ventricle and then
move the patient over to a catheterization laboratory
with X-ray facilities in order to gain a final position.
Therefore, we rarely, if ever, use a semi-floating
catheter to capture the ventricle.
Dr. Richardson: Is anybody using the Swan-Ganz balloon technique? Do they make a pacemaker catheter?
Dr. Dreifus: Yes, they do make a pacemaker. (Have
you used it?) Yes, we have used it. It is an excellent
catheter, incidentally, because it has a little balloon
that is inflated, and the stream will then carry it on
its way. Its most important use of course is to put it
in the pulmonary artery when you want to monitor
pulmonary artery pressure or something like that,
rather than as a pacemaker. But what Dr. Samet said
is true. You can pass a rigid catheter into the ventricle
without EKG control. Even though my machines are
constantly tested, I still have the fear of leakage in a
ground. We had a 3-prong plug ground on one of our
new Marquettes, and we had a 65 ma leak in that
machine. You never know when you are going to run
into this, and I have fibrillated patients. Even with
putting rigid catheters in under fluoroscopic control,
they may become displaced. So you must have golden
fingers.
Dr. Parsonnet: We have been playing with semifloating catheters for a long time, and again, Dr.
Zucker has one with a little parachute on the end of
it, like an umbrella, which guides the catheter into
the ventricle. Our experience has been much the same
as most other people's with these temporary electrodes. Even though you know where the tip is and
obviously you can tell that it is in the ventricle from
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the electrocardiogram, you don't know where the rest
of the loop is. The loop of the electrode can be in the
pulmonary artery, or up in the atrium, or in the ventricle. This insecure position of the loop can lead to
malposition, and then it will pass with a bolus of blood
and pull the tip out of position. The free-floating
catheters have knotted around themselves and around
trabeculae, and we have had to go after them. In our
experience, and the same with Tom Killip in New
York and others, about 20 percent have pacing failure,
even though they have been positioned with an electrocardiogram.
Dr. Baird: Dr. Samet, how do you verify your position
in blind insertion of the stiff catheter?
Dr. Samet: It is not important to verify it, because all
you want to do is put it into a position where you can
gain at least temporary pacing to control the situation
and then move the patient.
Dr. Baird: Do you rely on intracavitary electrocardiograms?
Dr. Samet: No.
Dr. Richardson: It seems to me that it is far safer than
EKG monitoring hooked up to 110 volts.
Dr. Narula: I just wanted to make a comment that if
you do want to use temporary pacing by the bedside
in an emergency situation, instead of hooking up the
catheter to the EKG for finding out the position, a
simple way may be to hook up the catheter to the
pacemaker so you don't defibrillate the patient by
EKG output. Then turn the pacemaker on a 5 or 10
ma, and when you get into the right atrium, you will
have atrial pacing and you just record a surface EKG.
When you get in the RV you will find ventricular pacing. This way you may bypass the problem of shocking the patient at the bedside. If you are in the
shoulder, you may have some muscle twitching, so
that it is much simpler to use this method.
Dr. Samet: I just want to emphasize one point again.
The term "bedside" has been used several times this
morning. When we use rapid atrial stimulation this is
not a bedside technique. It is a technique to be
used only under fluoroscopic control-not under
EKG control. You don't dare turn on rapid atrial
stimulation at 300, 400, 500, or 1000 without having
absolute fluoroscopic control of the tip of your catheter
or you fibrillate the ventricles. This was done once at
our hospital and fortunately the patient was revived.
So rapid atrial stimulation is not a bedside technique
in the sense of a technique in the ward, or even in the
ICU, away from X-ray facilities.

Electrical Instrumentation and Hazards*
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Electric current is both valuable and hazardous in
cardiac therapy. Small amounts of electric current
are enough to electrocute the patient, especially if
the current is delivered through a catheter in the
heart. It has been demonstrated that currents as low
as 10-15 microamperes are capable of inducing ventricular fibrillation. This minute amount of current
is actually a thousand times less than what you can
barely feel with your hand; nevertheless, this amount
of current, internally, can cause many problems.
Therefore, electrical equipment, when used, must be
used carefully. We must be careful of the amount of
current induced by capacitive coupling, or other
sources of leakage.
The problem becomes further complicated in a hospital where electrical equipment is used with inadequate maintenance. The most desirable situation would
be to have an electrical technician on the staff to
maintain the equipment, making certain that the
equipment has been installed correctly. Both the technician and the physician should have the responsibility
of insuring proper use of the electrical apparatus.
The manufacturer designs the equipment to work in
a certain environment; if it is used properly within
this environment, it is usually safe.
Presently, there is no perfect solution to the problems of electrical hazards in cardiac therapy. Although
electrical hazards are continually occurring due to improper wiring, it would be an enormous expense to
have all hospitals suitably rewired. Committees and
workshops have been created to study these problems.
In 1970, the National Academy of Sciences published
an excellent report on Electrical Hazards in Hospitals.
However, the complexity of the problem remains with
no universal solution.
What can be done and what can the physician do?
One recommendation is proper grounding; but for this
to be effective, proper grounding would have to correlate directly with the design of the equipment. Some
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equipment is designed to be used without ground.
Should the patient touch ground or any surface at a
different potential, a dangerous current may flow
through the patient.
Although solutions to individual problems are usually
found as each situation arises, there does not appear
to be, as yet, a universal solution.

PANEL DISCUSSION

Questioner: How are the devices for recognition of
electrical hazards in coronary units?
Mr. Berkovits: If you have a system that is designed
to be grounded, a testing circuit may detect when you
have a malfunction.
Questioner: What about the use of an electric bed?
Mr. Berkovits: As long as it functions properly you
have no problem. The question is whether or not the
convenience of an electric bed justifies the risk of a
potential danger. The electrical equipment in a coronary care unit should be kept to a minimum. When
functioning properly, the high isolation impedance of
this system will improve your reliability and safety.
However, capacitive currents and currents induced
magnetically in a magnetic field can be hazardous.
Dr. Zoll: I think it is important to mention that there
is a risk of electrical fibrillation not only in the coronary care unit, but in the operating room at the time
of implantation of pacemaker replacement. Several
of us have talked about the means to measure threshold at the time of operative manipulation at the end
of the catheter electrode. At this time, we attach the
electrode to a variable voltage source and a measuring device, usually an oscilloscope which is powered
by alternating current. Although some oscilloscopes are
now battery powered, every time one is connected, we
risk inducing alternating current ventricular fibrillation. However, in experienced hands, like those of Dr.
Parsonnet, this is a safe procedure. Before we attach
these instruments to the patient's catheter, we routinely
test for AC interference. With a quickly breakable
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connection we then attach the instruments. Jn this
way, if any ectopic interference activity is produced,
we can disconnect the instruments properly. Extreme
caution must be exercised when a low resistance pathway to the heart is exposed to the environment.
Mr. Berkovits: I would like to point out that in order
to avoid confusion in an emergency situation, there
should not be wires hanging in all directions. Whenever you work in this type of situation, you should
have a clear vision of everything that is happening.
Questioner: What is the value of a voltmeter?
Mr. Berkovits: If you have a battery-powered voltmeter, you can measure voltage, milliamps, and resistance, but because the leakage currents are minute
( 10-15 microamps), no conventional voltmeter will
detect them.
Questioner: Can AC-powered voltmeters be used?
Mr. Berkovits: AC-powered voltmeters do not offer
appreciable increased sensitivity in resistance measurements, and you run the risk of inducing dangerous leakage currents.
Questioner: Concerning the usage of electrical instruments, how can you provide for maximum safety?
Mr. Berkovits: Because each hospital has a different
wiring system, there is no single solution. A number
of recommendations have been made for the formation of committees. The National Academy of Sciences
has formed a committee on safety and hazards. Although they have not found a solution that would
apply to all electrical hospital equipment, they do
agree that the AC current delivered to the heart
should be kept below 10 microamps.
Questioner: Is the battery-powered oscilloscope safe?
Mr. Berkovits: It is safer than a conventionally
powered oscilloscope, but there are external conditions
that may create a danger regardless of whether an
AC- or DC-powered oscilloscope is used. Because electric currents can be inductively or capacitively induced,
any wire near the heart can act as an antenna and
induce more than 10 microamps.
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Questioner: What about the hazards of static electricity?
Mr. Berkovits: Static electricity gives only a single discharge and will appear as a single stimulus.
Questioner: Dr. Zoll, please make additional comments on external shock therapy for cardiac standstill in a straightline EKG with arrest.
Dr. Zoll: External electrical stimulation, properly
applied, will provide an effective and adequate stimulus to produce an electrical and mechanical response
if the heart is capable of responding. If one acts
quickly, within a matter of seconds after the onset
of arrest, the resuscitation from ventricular standstill by external electric stimulation is an effective
emergency measure that should be successful no matter what the background of the arrest may be. It is
most commonly done in patients with Stokes-Adams
disease with A-V blockage because these patients are
most commonly affected with ventricular standstill.
But, it is also effective in patients who have reflex
vagal stimulation and arrest, in patients who have
arrest due to drugs of one sort or another, in patients
who have so-called "unexpected arrest" in the operating room while under anesthesia, and in patients
with acute myocardial infarction. Because of the
availability of this method of resuscitation and the
availability of intravenous drug therapy, which can
also be used to maintain and restore cardiac rhythmicity, we are less eager to introduce all the complications, risks, and troubles involved by the use of
temporary cardiac pacing in many patients with acute
myocardial infarction. I agree that there is an important place for temporary pacing in acute myocardial infarction, but I strongly maintain that if one
is careful with patients with acute myocardial infarction, uses drugs properly, and stands by with emergency resuscitation, the need for catheter electrodes
and the corresponding risk can be greatly diminished.
I say that one must balance the various factors involved with one's clinical judgment and that one
doesn't need to use temporary pacing quite as often
as might be suggested today.

Case Presentations
CASE I:
A 43-year-old white male construction worker was admitted to the coronary care unit for evaluation of
left anterior chest discomfort.
How would you manage the following intermittent arrhythmia, which was noted shortly after admission?
Vital signs remained stable.
' Cl\MCO NO. 40 ..

CASE I

Dr. Baird: Dr. Dreifus, how would you manage this
patient's arrhythmia?
Dr. Dreifus: You have here a premature ventricular
systole which begins a run of slow ectopic beating
presumably from the ventricle. It is not occurring on
top of the T wave. The victim is in ventricular tachycardia at a rate of about 60 or 62, and it appears to
be a slow ventricular idioventricular rate without retrograde P waves. In this case I would try speeding up
the sinus rate with a little atropine to eliminate the
slow rate.
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Dr. Baird: Would any other panelists like to comment
or disagree?
Dr. Zoll: I would simply watch the patient and do
nothing else.
Dr. Parsonnet: In our coronary care unit with continuous monitoring, this is not an infrequent arrhythmia, though Dr. Samet has just whispered in my ear
that he sees it rarely in his unit. It is totally benign
and has no serious consequences, therefore it is not
treated.
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CASE PRESENTATIONS
CASE II:
This 75-year-old black male represents an arrhythmia related to digitalis toxicity.
Is temporary pacing indicated?

CASE II

Dr. Baird: This is a frequent problem in city hospitals.
There is no adequate history available on this patient,
but apparently he has been taking too much digitalis.
The question is, if he has atrial fibrillation with highdegree A-V block, how would you manage him during
the interim period?
Dr. Samet: First, how symptomatic is this individual?
Dr. Baird: He is confused, and he has been nauseated,
but there has been no evidence of Stokes-Adams
seizures. He has mild congestive failure.
Dr. Samet: Well, the rate here is in the low 40's. If he
is symptomatic with something that would be improved by increased rate, then I would pace him. If
he is not symptomatic with this arrhythmia, and if I
felt it was due to digitalis, I would not pace, but stop
the digitalis and just watch him. One point I want to
stress is that when high-degree A-V block is a manifestation of digitalis toxicity, the administration of
potassium is inappropriate and may have untoward
consequences. If this is just complete heart block, then
the potassium may have no further block-producing
tendencies.
Dr. Baird: How do the other panelists feel? Dr. Dreifus,
are you concerned about pacing a patient who has an
arrhythmia due to digitalis?
Dr. Dreifus: I think if he is confused, I would do as
Dr. Samet stated. The question is whether or not be is
symptomatic. Now there is some controversy over
potassium. I would tend to agree that if in the sub166

junctional regions you give enough potassium or give
it too fast, you will cause further block. However,
there is no doubt that potassium will antagonize digitalis in the N region of the A-V node and increase
conduction. If the serum potassium were depressed
and if I were worrying about causing further depression, I would then pace the patient and still administer
potassium.
Dr. Baird: Thank you. What are the hazards with
temporary pacing in patients with digitalis-induced
arrhythmia? What has been your experience in this
situation?
Dr. Dreifus: What you are worried about is the mechanical stimulation of that catheter number 1 and 2.
If you induce a propagated response from the pacemaker on top of T wave in an over-digitalized patient,
is the ventricle more vulnerable? Yes, the ventricle is
more vulnerable, and the risk is increased. But with
proper placement and prophylactic use of agents while
you are passing the catheter and with great skill and
few premature ventricular beats, this is really not a
problem.
Questioner: What is your attitude toward treating this
patient with dipbenylhydantoin?
Dr. Dreifus: I don't think diphenylhydantoin would be
of value in this instance. In the concentrations used
clinically, we have shown that it increases block in the
A-V node. If there were ectopic ventricular beats with
block here, I certainly would avoid drugs and go the
pacing route.

CASE PRESENTATIONS
CASE Ill:
This patient with a permanent pacemaker developed substernal pain and hypotension.
Would sympathomimetic amines be helpful to restore his blood pressure?

CASE Ill
Dr. Baird: Dr. Zoll, how do you feel about the concomitant use of sympathomimetic amines in patients
with pacemakers?
Dr. Zoll: With the functioning permanent pacemaker
in place, one would treat hypotension with drugs as if
the patient were in normal sinus rhythm. As long as
the pacemaker rate is reasonably rapid, as in this case,
the appropriate vasoconstrictor agents (i.e., neosynephrine or isoproterenol) can be used. Most of these
drugs do have a tendency to arouse ectopic activity as
well as acceleration of dominant rhythm; however,
with a well-functioning pacemaker, a positive inotropic
action is not immediately seen.
Dr. Samet: My first reaction after seeing this tracing
would be to ask for other leads. While this tracing
probably represents paced beats followed by a T wave,
I am not mathematically certain whether or not these
other beats represent premature beats. I would have
to see other leads in order to be certain.
Dr. Baird: I have used this case to suggest that in certain patients sympathomimetic amines might lower the
threshold for ventricular fibrillation, and there might
be instances in which untoward administration of these
drugs might precipitate ventricular tachyrhythmias.
Anybody have any comments or experience with this
situation? Dr. Dreifus?
Dr. Dreifus: Yes. I learned my lesson on the cardiac
surgery table where we used a good deal of sympathomimetic amines, particularly isoproterenol. Beyond a flow of 3 micrograms per minute of isoproterenol, you will get increased ectopic beating that
could be fatal to the patient. Therefore, it is a matter
of degree how you use these agents. I don't think we
can say that they are all good or all bad; we should,
however, be aware of the dangers and the limitations
of administration.

Dr. Zoll: Isoproterenol clearly does arouse and accelerate ventricular pacemakers. There is a definite
risk with isoproterenol; but if o!'le gives the drug in a
diluted solution, say 1 or 2 micrograms per minute,
we can then step it up every several minutes. We
usually change the dose every 4 or 5 minutes, watching what is going on all the time. You can keep on
going until you get either the desired therapeutic effect
of an increased cardiac output or increased blood pressure. If untoward effects appear (i.e., ectopic beats) ,
reduce the dosage or adjust the administration of the
dosage until no adverse effects are seen. There is no
real limit as to how much you should give a patient.
We have given over 30 micrograms per minute of
isoproterenol to some patients with complete heart
block, in what I consider to be a safe and effective
way. On the other hand, some patients might run into
trouble with a much smaller dose, in which case you
stop and take care of the situation accordingly.
Dr. Samet: The arrhythmic effects of the vasoconstrictors really have two aspects. One is the direct aspect
which has been alluded to, and the other is an aspect
which follows the development of hypertension. That
is, when one gets the desired effect by overshooting
the mark, reflex arrhythmias secondary to hypertension can develop. Which leads me to my next point:
One of the things we have learned to mistrust is the
peripheral arterial pressure under these circumstances.
We have, in a number of instances, obtained hypotensive readings with the usual blood pressure determination. Because you can readily overshoot the mark,
we prefer monitoring the arterial pressure interarterially almost routinely when we feel we have to administer vasopressors. So I warn you not to trust the
routinely determined blood pressures in these hypotensive patients.

167

CASE PRESENTATIONS
CASE IV:
This 70-year-old white male was admitted for hematologic evaluation when he suddenly developed chest pain
and acute EKG changes suggestive of diaphragmatic myocardial infarction. Several days later, he was placed
on oral procainamide to suppress VPC's. However, the following arrhythmia developed.

CASE IV

Dr. Baird: Dr. Narula, how would you manage the
patient in this situation?
Dr. Narula: This looks to be a very interesting arrhythmia which terminated spontaneously. Because of
the sudden sinus beat, the possibility of fusion beat is
Jess likely. Therefore, I would say it is probably
another ectopic beat which suppresses the ventricular
tachyrhythmias and gives the sinus rhythm a chance.
Dr. Baird: You would give more suppressant drug
therapy?
Dr. Narula: Because sinus rhythm is fairly stable in
this patient, within the normal physiological range, I
think this patient would require suppressant therapy.
Dr. Baird: Any other comments?
Dr. Samet: In this discussion about the treatment of
cardiac arrest and ventricular arrhythmia, I would
like to stress that Dr. Zoll and I were just talking
about a very simple physical mode which does really
work; we have seen a blow on the chest administered
by a clinched fist stop ventricular fibrillation; we have
also seen it restart the heart that was arrested in just
a few seconds.
Dr. Parsonnet: I would like to add that as far as
therapy in the cardiac care unit is concerned, there is
a tendency to worry about the electrocardiogram and
forget about the other things happening to the patient.
For example, a person who has been in the intensive
care unit for a few days, hypoventilating and getting
all kinds of drugs, may have serious abnormalities in
their blood gases and blood electrolytes. Before you
rush off and start using a lot of other things, I think
you ought to make sure that you have a normal

electrolyte balance. Sometimes, by simply directing the
blood gases or blood electrolytes, you can stop the
arrhythmias.
Dr. Dreifus: I agree with Dr. Parsonnet; you have to
look for other problems. But remember, these ventricular premature beats are bisecting the T wave. In
other words, the onset is very close to the T wave, and
vasoconstrictors will respond to drugs like lidocaine
and procainamide. This repeated occurance in the
development of fibrillation brings up an interesting
hiatus in drug therapy: Do we use a drug like procainamide or lidocaine, which actually decreases fibrillation threshold, or do we switch to an agent like
bretylium? We just might end up treating these arrhythmias with bretylium when they are prefibrillatory
or fibrillatory. If there are single ventricular premature
systoles, you may take the lidocaine approach first just
to get rid of the ectopic beating period. However, if
they are prefibrillatory, as in this particular record, we
may be using bretylium in the future. I think you had
better keep a very close eye on the literature to see
where we go from here.
Dr. Baird: Dr. Samet, do you agree with Dr. Dreifus's
enthusiasm in regard to bretylium?
Dr. Samet: If we are talking about bretylium as a drug
of initial approach, I do not agree. However, if we are
talking about bretylium as a drug to be used when
others have failed, then I agree emphatically. There
are side effects with bretylium even in the horizontal
position which does not make it the drug of initial
choice. We still rely upon lidocaine, quinidine, procainamide, etc., but have used bretylium with success on
a number of occasions. The role of bretylium has to be

CASE PRESENTATIONS
kept in proper perspective.
Dr. Richardson: What about procainamide as an inciting drug?
Dr. Baird: Well, that's a point I was trying to emphasize. Dr. Dreifus, when ventricular tachyrhythmias
revert spontaneously, doesn't this give you a clue that
quinidine or procainamide was induced?
Dr. Dreifus: No.
Dr. Baird: Do any of the panelists have experience
with recurrent ventricular fibrillation due to quinidine?
Our experience is, in a limited number of cases, that
they do not require defibrillation, but may be controlled with overdrive pacing.
Dr. Samet: Would you tell us a little more about the
circumstances developed? I suspect that some of those

cases do not represent quinidine sensitivity but inappropriate use of quinidine.
Dr. Baird: That is an important point in determining
whether it is really a toxic effect, a rate-dependent
problem, or an effect related to a true sensitivity as
originally described; but this a point of argument. The
procainamide was stopped and the patient's ventricular irritability decreased. He did not require any overdrive pacing as a technique suppressing drug-induced
recurrent ventricular tachyrhythmias.

Dr. Narula: Could it be that the chest pains and the
ischemic changes disappeared with time and were responsible for the disappearance of the arrhythmia
rather than the discontinuance of the procainamide?
Dr. Baird: No.

CASE V:
A 2 ¥2 -year-old child was in excellent health until he developed a viral illness, which was complicated by
rapid heart rate. Initial therapy was digitalization to control "PAT." This failed and recurrent bouts of
"VT" required 350 countershocks ( 100-200 W.S.) .
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CASE PRESENTATIONS
CASE V

Dr. Baird: Here we discuss the advantages and disadvantages of pacing. I have just mentioned the fact
that atrial overdrive for ventricular pacing may control
a certain arrhythmia. In this case the child, who had
been in excellent health, developed a flu-like syndrome
associated with recurrent bouts of tachyrhythmia.
At first it was thought that these were paraoxysmal
atrial tachycardia. However, an intra-atrial lead demonstrated clearly dissociation between the atrial activity and the ventricular rhythm disturbance. The diagnosis was made that this was recurrent ventricular
tachycardia in a child who possibly bad some type of
myocarditis or myocardiopathy. Assuming the diagnosis is correct, what would you recommend in the
way of pacing or drugs to control this particular problem? The child bad been given 350 countersbocks by
the pediatric service for recurrent bouts of ventricular
tachycardia associated with bypotension. Dr. Dreifus,
what are your thoughts on this problem?
Dr. Dreifus: Obviously this is a very difficult situation.
I have not seen ventricular tachycardia very often in
children. The use of digitalis here is contraindicated
under the circumstances. I am not at all convinced
that this is ventricular tachycardia. It could be junctional with aberrant conduction. Atrial pacing might
work in this case if you could get the catheter to stay
in place, but that is tough in a kid. Ventricular pacing
may also work, but that too is difficult. What I have
dealt with in children is the use of propranolol and
quinidine. The problem is getting them to take that
combination because it tastes terrible. But sometimes
that will control the ventricular tachycardia. I have
not used bretylium, but I think that if I had my choice
after all the electricity that has passed through this
kid, I might say this is one of the prefibrillatory or
prerepetitive situations and switch to a drug like
bretylium rather than push my luck with the other
depressant agents.

170

Dr. Baird: Before we comment on bretylium, do you
think there is any clinical trial justification of internal
defibrillation?
Dr. Dreifus: I don't know that we could do it in a
child though we do it in dogs. It takes a lot of hardware, and I am wondering if it would really be practical in the end. It works, but maybe Mr. Berkovits
will have some ideas on how to develop the electronics
to improve it. I would try to solve all problems like
this pharmacologically rather than on an internal or
external defibrillation basis. Once the patients are put
on a prophylactic pharmacological treatment, the arrythmia usually goes away.
Dr. Baird: Any other comments? After bretylium was
administered intravenously in this child, acceleration
of the ventricular rate occurred. Whether continued
administration of bretylium would have been effective
as an antiarrhythmia, I don't know. After I had caused
rate acceleration with the drug, I was no longer asked
to follow the patient. Dr. Dreifus?
Dr. Dreifus: Small doses of bretylium do have a tendency to aggravate the arrhythmia. There is no doubt
about it. There are some electrophysiological reasons
why this might occur. The trick is to use enough, but
using bretylium in a kid for a rather unknown problem is risky. You may have been right to back off. I
might have tried a large dose.
Dr. Baird: It has been an enjoyable day and a half.
I would like to acknowledge the moderators, Drs.
Richardson * and Drew * as well as the panelists for
the support and advice required to make this a successful program.
* DONALD w. DREW, M.D., Director of Cardiology and
Acting Director of Internal Medicine, Norfolk G eneral
Hospital, Norfolk , Virginia.
* DAVID w. RICHARDSON , M.D. , Professor of Medicine,
The Medical College of Virginia, Richmond, Virginia.
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